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Abstract
This thesis describes the development of a procedure for comparing the manner in which 
organic solvents inhibit biocatalysts. The research compared the effect of a series of 
primary alcohols on a membrane bound and a soluble cytochrome P450 hydroxylase.
The effect of alkanes and primary alcohols on the bioluminescence of luciferase (EC 
1.13.12.7) was developed as the basis of a fast and stable bioassay for measuring the 
aqueous concentration of a primary alcohol or an alkane (Franks & Lieb, 1984). This 
was then used to determine the concentration of organic solvents in the aqueous phase of a 
mixture of biological membranes and water.
The bioassay was used in a study of the effect of primary alcohols on two cytochrome 
P450 hydroxylases. The first was a purified and soluble cytochrome P450, derived from 
Bacillus megaterium (recombinant P450 BM3 engineered for high expression in 
Escherichia coli (kindly supplied by Dr Munro at the University of Edinburgh)) and the 
second a membrane associated enzyme present in Rhizopus stolonifer (formally known as 
R. nigricans).
The effect of the solvents in the reaction mixture was characterised by their IC50 value, that 
is, the concentration of the solvent that caused a 50 % inhibition of the enzyme activity. 
The soluble enzyme from B. megaterium was found to be more strongly inhibited by short 
chain alcohols (IC50 for methanol = 0.71 M) than the enzyme from R. stolonifer (IC50 for 
methanol =1.63 M).
The inhibition of both enzymes by the primary alcohols becomes more extreme as their 
molecular weight increased, and they were almost equally inhibited by pentanol (IC50 
=62 mM and 46 mM respectively). Hexanol inhibited the enzyme from R. nigricans (IC50 
=25 mM) but was not sufficiently soluble in water (solubility limit is 50.1 pM at 
25°C,Bell, 1972) to inhibit the enzyme from B. megaterium.
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The aqueous concentration of various primary alcohols and alkanes in the presence of the 
cells of R. stolonifer suggested that at 50 % inhibition the molar concentration of the 
solvent in the membranes of the cells was the same for all the alcohols studied.
The log IC50 (the logarithm of the concentration of the alcohols that caused a 50%  
inhibition of the enzyme activity) was found to be a linear function of the carbon chain 
length of the alcohol and decreased regularly as the chain length increased. A multiple 
regression analysis showed that the effect of the series of primary alcohols on the two 
hydroxylases studies was significantly different.
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1. Introduction
1.1 Catalysis and Biocatalysis
1.1.1 Introduction to biocatalysis
A chemical reaction mediated by material derived from a biochemical process is termed 
biocatalysis. Biocatalytic processes are generally single step enzymatic reactions and so 
can be distinguished from fermentations, which involve primary metabolic pathways. The 
enzymes can be used in either a purified form, in a semi-pure form, for example as 
microsomal or peroxisome preparations, as crude extracts, or in whole cell systems. These 
protein based catalysts can originate from microbial, yeast, fungi, mammalian or plant 
cells. They can be used as free entities or an immobilised form.
1.1.2 Advantages of biocatalysis over chemical synthesis
The protein structures of enzymes with unique functional groups at the catalytic site. The 
protein structures of enzymes with unique functional groups at the catalytic site confer a 
high degree of specificity in the catalysis. On a molar basis enzymes usually have a faster 
turnover than the lower molecular weight catalysis used and organic reagents. The 
reactions usually take place under ambient conditions (at 20-40°C although some can 
withstand temperatures up to 100°C (Ghogare and Kumar 1989). Enzymes also require 
mild aqueous conditions rather than aggressive organic reagents, and they rarely need 
protection from a normal atmosphere of nitrogen and oxygen.
The major advantage of biocatalysis in terms of the fine chemical and pharmaceutical 
industry is that enzymes can exhibit high chemo-, regio- and enantioselectivity (Hailing, 
1990). One example where biocatalysis have replaced a chemical conversion is the 
production of 6 -aminopenicillanic acid (6 -APA). Figure 1-1 shows the chemical and 
biochemical route (Tramper, 1996). A productivity of up to 2000 kg of 6 -APA per kg of
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immobilised enzyme is obtained with operating lifetimes in excess of 10 hr (Tramper, 
1996).
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Figure 1-1 Production of 6 -aminopenacillanic acid (6 -APA) from penicillin.
G or V by biocatalysis and chemical synthesis (Savidge, T.A, 1984)
1.1.3 Limitations of biocatalysts
Most enzymes are highly selective and will react with only one substrate. They have a low 
stability, are prone to thermal inactivation and show maximum activity in a narrow range 
of pH, temperature and ionic strength of media. If the reactant or product (in many cases
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both) are hydrophobic or poorly water soluble, then the rate of the catalysed reaction and 
the concentration of products in the solution is limited. Hydrophobic organic solvents can 
be used to increase the solubility of reactants and products to enhance the reaction 
productivity (Zaks and Klibanov, 1984). However, these organic solvents tend to be 
toxic to enzymes (Zaks and Klibanov, 1985). Recent work is expanding the field of 
biocatalysis in water poor systems in anhydrous solvents, two-phase systems or in water 
miscible co-solvent systems (Koskinen and Klibanov, 1996).
1.1.4 Advantages of whole cell biotransformations
Some biochemical reactions require cofactors, which are readily available and are recycled 
in living cells. Oxidations and reductions often require complex nucleotides such a NAD+ 
and NADP+ or there reduced forms NADH and NADPH. ATP, which acts as an energy 
source is required to drive many cellular reactions (Volt, et al, 1998).
To maintain enzyme activity in the purified form, the cofactors must be recycled. This 
adds to the cost of the catalytic reaction and can be a limiting factor in the economics of 
the total process.
Another problem associated with purified biocatalyst is the difficulty in obtaining active 
preparations of membrane bound enzymes, for example, the cytochrome P450 
hydroxylases. The enzymes interact with the biomembrane, which confers conformational 
information essential for catalytic activity. Thus, when the enzyme is removed from the 
hydrophobic support and the conformational information is lost, in many cases activity is 
reduced (for references see section 1.10). Generally, these enzymes are only stable when 
attached to a hydrophobic support (Akita, 1996). To maintain their activity after 
purification conformational state and the range of motions allowed must be maintained. 
This is very difficult to achieve and activity is usually lost when moving enzymes from 
biomembranes to an aqueous phase (Akita, 1996). One can imagine direct transport of 
enzymes from cellular membranes to synthetic hydrophobic supports but the engineering 
associated with the change is not well understood. Whole cells are also known to protect 
enzymes from contact with air-liquid and liquid-liquid interfaces preventing protein 
conformational changes and loss of activity (Ushio, 1983). In addition, the whole cell 
modulates protease expression, provides a controlled pH, and the ionic strength
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environment important for enzyme activity (Holland, 1998). An example of an industrial 
whole-cell biocatalysis is the production of indigo (Figure 1-2; Cameron & Tong, 1993).
In the whole cell system there is no requirement for cofactor recycling. The high costs 
associated with purifying cytoplasmic enzymes, and the availability of active membrane 
bound enzyme systems, confer advantages of employing whole cell techniques.
For purified enzymes, the low solubility of hydrophobic substrates and products in the 
aqueous phase is a limitation of the whole cell biocatalytic process.
D-glucose
E. coli enzymes
u
indole
P. putida naphtalene 
dioxygenase
H
cis-indole 2,3-dihydrodiol
spontaneous (-H2O)
▼
indoxyl
spontaneous (-H2O)
u
indigo
Figure 1-2 Biosynthesis of indigo by recombinant E. coli cells 
(Endley, 1983)
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The next section of this introduction (1.2-1.6) will consider aspects of the interaction of 
solvents with cell membranes in more detail, and this includes sections (1.5-1.6) on 
solvents as general anaesthetics, a process which is similar to the effects of solvents on 
biotransformations. This is followed by a section, (1.7) on the oxidative processes 
catalysed by the membrane bound enzymes of the cytochrome P450 group.
The effect of a series of alcohols on two of these important oxidative enzymes forms the 
experimental basis of this study, the rationale for which is set out in the final section ( 1 .8 ) 
of this introduction.
1.2 Biocatalysts in non-aqueous solvents
The addition of water miscible organic solvents to an aqueous system can be used to 
increase the solubility of substrates and products of an enzymatic reaction (Verger, 1997). 
Thus, higher concentrations of both substrates and products can be contained. The rate of 
reaction increases and the equilibrium position of the reaction is shifted because products 
are more readily partitioned from the cell. The higher concentration of substrate improves 
the process economics. The disadvantage of using organic solvents lies in their toxicity to 
living cells. Life on earth is based on water. Organic solvents did not play a prominent 
role in the evolution of living systems. However, biological systems can produce large 
local quantities of water miscible organic acids and alcohols. The concentration of these 
hydrophilic compounds required for toxic effects are high. Very lipophilic compounds 
such as olive and vegetable oils are not toxic at any concentration to whole cells. Toxic 
solvents are typically more hydrophilic than long chain oils and fats and more hydrophobic 
than short chain alkanes and acids. Attempts to understand this toxicity initially centred 
on the solvents physical properties of the solvents (Garbe, and Yukawa, 1991).
1.2.1 Parameters reflecting solvent toxicity
Solvents can be described by physical characteristics such as: Molecular weight (M), 
shape, viscosity, surface tension and electrical properties such as specific conductivity, 
dielectric constant, dipole moment, the ability to form hydrogen bonds and polarisation.
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Attempts have been made to correlate these physical properties with biocatalyst stability 
and solvent tolerance (Maroni & Barbieri, 1989).
1.2.1.1 The Hilderbrand solubility parameter
The Hilderbrand solubility parameter is defined as the square root of the cohesive density 
of a solvent (Hilderhrandt et al., 1970), and is an indication of the hydrophobicity of a 
solvent. (Brink & Tramper 1985) correlated the activity of calcium alginate immobilised 
Mycobacterium sp. to the Hilderbrand solubility parameter (Figure 1-3). They found a 
higher correlation with the activity when the Hilderbrand solubility parameter was linked 
to molecular weight (M).
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Figure 1-3 Activity retention of epoxidising, immobilised cells exposed to 
different organic solvents versus the Hilderbrandt solubility parameter (8).
It was deduced that the high activity retention was usually favoured by a low solvent 
polarity in combination with a high molecular weight. The key parameter in the 
Hilderbrandt solubility expression (Equation 1-1) is the solvent heat of vaporisation (AHV 
). AHV strongly depends on polar interactions between solvent molecules. So, for
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relatively apolar solvents versus the Hilderbrandt solubility parameter is relatively 
insensitive to differences in polarity.
Equation 1-1 AHV is the latent heat of solvation, (a measure of cohesive 
energy), v is the molar volume, R the gas constant, T is the absolute 
temperature (°K). (Laane et al, 1987).
1.2.1.2 Partition of Solvents into octanol (Log P)
Another more direct parameter reflecting the polarity of solvents is Log P, defined as the 
logarithm of the partition coefficient (P) of a given compound in the standard octanol 
water two-phase system (Equation 1-2).
V [Solute] J
Equation 1-2 Partition coefficient of a given compound in the standard 
octanol water two-phase system
Log P values can be determined experimentally or calculated from hydrophobic fragmental 
constants (Rekker, 1977). (Laane et al., 1985) re-plotted the data from (Brink & 
Tramper 1985) using calculated log P values. They obtained a higher correlation between 
the activity and the solvent polarity when log P values were used (Figure 1-4). (Laane et 
al., 1985) also re-plotted the data from (Playne & Smith 1983) and found a clear 
correlation between log P and in that case the relative gas production activity of suspended 
anaerobic cells. The classic S shape of these log P activity plots suggested that the cells 
were strongly inactivated by solvents with log P values of between 2 and 6. This type of
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curve was obtained with bacterial cells (Harrop et al., 1989) and isolated enzymes (Zaks 
and Klibanov, 1985).
In a bioreactor, the choice of solvent affects its compatibility with the microorganism. 
Elucidation of the mechanism of inhibition however cannot be obtained using the 
empirical data. An investigation of the molecular interaction of solvents with proteins and 
the interaction of membranes may provide information relating to the effect of solvents on 
the membrane bound enzymes, which is dependent on Log P. This is discussed further in 
section 1.3.
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Figure 1-4 Activity retention of epoxidising, immobilised cells exposed to 
different organic solvents verses log P.
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1.3 Effect of solvents on enzymes
In this section, the effect of organic solvents on purified enzymes is discussed. The four 
types of water poor systems are introduced and the advantages of removing water from the 
bulk phase of a two phase system are illustrated.
1.3.1 The importance of water for enzyme activity
Water is an absolute requirement for the catalytic activity of all enzymes, including those 
located within the cell membranes (Klibanov, 1986). Water is important in all non- 
covalent interactions that help to maintain the conformation of enzymes, necessary for 
activity. It is easy to understand the importance of water close to the protein, but what 
function does the water in the bulk environment play and what effect does the solvent have 
on the water concentration? It is assumed that the function of water is limited to forming 
bonds with polar amino acids on the enzyme surface. If the bulk water is removed by an 
organic environment, the enzyme will not be affected (Klibanov, 1986) and the systems 
are called reduced water systems.
1.3.2 Reduced water systems
There are four main types of water poor systems; almost anhydrous solvents (Klibanov, 
1997), aqueous organic two phase mixtures (Brink et al., 1988), enzymes in reversed 
micelles (Khmelnitsky et al., 1992) and enzymes contained within water-miscible organic 
co-solvents such as methanol and DMSO (Klibanov, 1996). In the first three cases the 
enzymes are situated in an aqueous phase, which is surrounded by an organic phase. In the 
last case bulk phase water is removed and replaced by the organic solvent. The first three 
cases are immediately important in relation to the microorganisms. Anhydrous solvents 
have more relevance when purified enzymes are used. In this case a low concentration of 
water, <1% ,  remains and this seems to be important for enzyme function (Klibanov, 
1996).
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1.3.3 Vital water
Solvents with log P > 5 tend to be non-toxic. This can be related to the ability of the water 
in the microenvironment of the enzyme to partition into the bulk phase. Highly 
hydrophobic solvents have a low solubility for water and so the tendency for the ’essential 
water’ to be striped away from the enzyme is low and the active conformation is 
maintained (Klibanov, 1986). Solvents with lower log P values have a higher solubility 
for water and can remove the vital water more readily. But very low log P solvents can be 
used as co-solvents (Bell, et al, 1995).
1.3.4 Advantages of removing bulk water
Most enzymes have an excess of hydrophilic groups on the surface, and tend to have a low 
solubility in an organic phase. This low solubility leads to the 'pH memory effect.’. All 
enzymatic reactions in aqueous environments are highly pH sensitive. Enzymes in organic 
solutions remember the pH of the last aqueous media. At a molecular level the ionisation 
state of the ionogenic groups on the surface of the enzyme are conserved and the activity 
associated with that pH is also conserved.
Another effect of reducing the volume of water available to the enzyme is the increase in 
the conformational rigidity. For example, porcine pancreatic lipase does not react with 
large substrates in anhydrous organic solvents. In this example solvent restricts 
conformational movement that allows the active site to relax in order to accommodate new 
substrates (Klibanov 1986).
In water, enzymes are irreversibly inactivated at high temperatures (Ahern & Klibanov, 
1985). Over a small rise in temperature, the amplitudes of all bond motions increase and 
the protein will reversibly unfold. Any loss of activity associated with this rise in 
temperature will be restored as the temperature is reduced.
Larger increases in temperature will result in formations of other functionally incorrect 
structures. Destruction of disulphide (S=S) bonds via P-elimination, deamination of 
asparagine and glutamine residues and hydrolysis of peptide bonds at aspartic acid residues 
are all possible chemical changes, but they all require water. If bulk water is removed the 
inactivation of enzymes at high temperature should be reduced in organic solvents. This 
can be seen with porcine pancreatic lipase at 100 °C (Zaks & Klibanov, 1984).
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1.4 Effect of solvents on living cells
The effects of organic solvents on whole cell biocatalysts cannot be discussed without an 
overview of the structure of whole cells. This section describes the mechanics of the 
bacterial cell wall and the differences between gram negative and gram positive bacteria. 
Membrane proteins and the Fluid Mosaic Model of the membrane are also reviewed. The 
section continues with the interactions of solvents with the membranes, including a further 
development of log P in relation to the solubility of solvents in the biological membranes. 
The adaptive mechanisms and evolution of microorganisms to natural and xenobiotic 
solvents ends the section.
1.4.1 Architecture of whole cells
Eukaryotic cells are highly developed and have a nucleus containing DNA surrounded by a 
nuclear membrane (Volt et al, 1998). The cytoplasm surrounds the nucleus and is 
subdivided into a variety of compartments. In addition, biological membranes surround 
mitochondria. The endoplasmic recticulum, ribosomes and golgi apparatus are all 
organelles found in animal cells and are important in enzyme production and modification. 
A semi-permeable phospholipid membrane surrounds the cell.
Prokaryotic cells are less developed. They have no mitochondria and the DNA is not 
contained within a nucleus. Bacterial membranes consist of several layers. Two layers are 
osmophilic, each about 2-3 nm thick, surrounded by a layer 4-5 nm thick. The membranes 
of bacteria, plants, and animals show considerable resemblance in their general structure. 
The bacterial membrane is rich in phospholipid. Membrane lipids constitute about 70- 
90 % of the cellular lipids, whereas the membrane constitutes only 8-15 % of the cellular 
dry weight. The cytoplasmic membrane consists of a lipid bilayer, with the hydrophobic 
groups exposed on the exterior surfaces. The bilayer has proteins incorporated into it. 
These are the integral membrane proteins, which can be considered as floating in the 
membrane matrix, some completely traversing it, whilst others are partially immersed. 
Other proteins are attached to the membrane and are described and peripheral membrane 
proteins. Some membranes are covered on one or both surfaces by a network of elongated 
proteins (Schlegel, 1988).
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The membrane should be considered as a very soft, deformable, almost fluid structure. 
Isolated membranes have a tendency to round up into vesicles with fragments fusing along 
their edges (Schlegel, 1988).
1.4.2 Bacterial cell walls
Microbial cell envelopes are elastic, highly complex structures. The cell envelope is 
composed of the cell wall and cytoplasmic membrane. The chemical structure of the cell 
wall varies between genera but the cytoplasmic membrane remains essentially the same. 
The cell envelope protects the microorganism against osmotic shock, allowing them to live 
in hypotonic (less than intracellular salt concentrations) environments that would 
otherwise cause them to swell osmotically until their plasma (cell) membranes lysed (Volt 
et al, 1998).
1.4.2.1 Gram-positive and gram negative bacteria
Bacteria can be classified as gram positive or gram negative depending on whether or not 
they take up gram stain. Gram-positive bacteria have a thick (~250A) cell wall 
surrounding their plasma membrane, whereas gram-negative bacteria have a thin (~30 A) 
cell wall covered by a complex outer membrane (Volt et al, 1998).
Gram negative microorganisms also have a periplasmic space, which separates the cell 
wall from the plasma membrane. Lipopolysaccharides (LPS) are randomly positioned and 
cover 30-40% of the outer surface on the outer membrane. They are highly hydrophilic 
and so provide protection against the passage of hydrophobic molecules (Bull et al., 1982). 
The cell wall is composed of a highly cross-linked peptidoglycan structure. It can vary 
between 0.8 and 30 nm in diameter and forms an anionic sieve-like structure enabling 
lipoproteins to have a rigid base to anchor on. Solvent passage through the peptidoglycan 
layer occurs unhindered. When a solvent interacts with the cytoplasmic membrane, 
expansion may occur and microscopic observation has showed membrane expansion 
(Bull, 1982).
1.4.2.2 Lipids and membranes
The function of lipids is to organise biological processes by compartmentalising them. 
They are substances of biological origin that are soluble in organic solvents such as
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chloroform and methanol but are only sparingly soluble, if at all, in water. Lipids can 
aggregate to form micelles and bilayers. Bilayers are the structural basis for biological 
membranes (Binder, et al., 2004).
In aqueous solutions, amphiphilic molecules such as soaps and detergents form micelles. 
This molecular arrangement eliminates unfavourable contacts between water and the 
hydrophobic tails of the amphiphiles (Binder, et al., 2004).
1.4.3 Biological membranes
Biological membranes are composed of proteins associated with a lipid bilayer matrix. 
Their lipid fractions consist of complex mixtures that vary according to the membrane 
source and to some extent with the diet and environment of the organism (Eichler and 
Irihimovitch, 2003).
1.4.4 Membrane proteins
Membrane proteins can be classified according to how tightly they are associated with the 
membranes.
Integral or intrinsic proteins are tightly bound to membranes by hydrophobic interactions 
and can be separated from them by treatment with agents that disrupt membranes. These 
include organic solvents, detergents, and chaotropic agents (ions that disrupt water 
structure). Cytochrome P450i i« in R. stolonifer is an example of an integral membrane 
protein. (Domanski & Halpert, 2001).
Peripheral or extrinsic proteins can be dissociated from membranes by relatively mild 
procedures that leave the membrane intact, such as exposure to high ionic strength salt 
solutions, or pH change. Cytochrome c is an example of a peripheral protein that is stable 
in aqueous solution. (Kim et al., 2000).
1.4.5 Fluid Mosaic Model of Membrane Structure
In this, the Fluid Mossaic Model of Membrane Structure (Slinger, 1974), integral proteins 
are able to freely move laterally over a two-dimensional ‘sea’ of lipid unless associations 
with other cell components restrict their movements. This model has been verified 
experimentally by the fusion of cultured mouse cells with human cells by treatment with
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Sendia virus to yield a hybrid known as a hetrokaryon. After 40 min. at 37 °C cell proteins 
of the mouse, cell and human cell were observed to be randomly distributed over the 
hetrokaryon (Slinger, 1974).
1.4.6 Partitioning of solvents into biological membranes
The measure of log P can be used to estimate values for partitioning of solvents in to 
membrane-buffer systems (Osborne et a l, 1992). Hydrophobicity however is not the only 
parameter that affects solvent solubility into membranes. The molecular structure of a 
solvent will alter its ability to migrate into a phospholipid bilayer. Amphiphilic molecules 
that have both hydrophobic and hydrophilic centres have structures that mimic the 
phospholipid nature of cell membranes and can dissolve more readily (Saunders, 2003). 
An example being the phenols, which are relatively more toxic than other compounds 
(Kitagawa et al., 1990). The composition of the membranes also influences the solubility 
of the compound into the membrane. For example, the partition coefficient of lindane is 
50 times higher in liposomes of dimyristoyl-phospatidylcholine (C l4:0) than in liposomes 
of diasterroylphosphatidyl-choline (C l8:0) (Antunes-Madeira & Madeira, 1989).
1.4.7 Influence solvents on lipids and membranes
Once a solvent molecule has partitioned in to the membrane it will be incorporated into the 
structure and hence disturb the integrity and the complex system of phospholipids and 
proteins. Techniques for investigating membrane integrity include the use of fluorescence 
labelled liposomes. Any expansion of the membrane caused by an influx of solvent will 
tend to dilute the radio labelled probe and indicate membrane swelling as a function of the 
reduction in radio signal (Saunders, 2003).
1.4.8 Adaptation to natural solvents
The resistance of microorganisms to ethanol mediated by changes in the structure has been 
reviewed (Ingram, 1984). The composition of the membranes is altered either by 
increasing the chain length of the fatty acid chain, or by increasing the proportion of Cis- 
monounsaturated fatty acids. Both mechanisms have been encountered in Lactobacillus 
homohiochii and L. heterohiochii (Ingram, 1984).
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The ratio of unsaturated to saturated fatty acids is increased in the presence of ethanol in E. 
coli and liposomes with a high content of unsaturated fatty acids were shown to exhibit 
increased fluidity. Membranes from cells grown on ethanol have a higher proportion of 
membrane proteins (Heipieper, Keweloh & Rehm, 1991). The increase in the protein 
lipid membrane has been shown to increase the rigidity of the cellular membrane.
1.4.9 Adaptation to xenobiotic solvents
Increasing the degree of saturation of membrane lipids is one method of adaptation to 
xenobiotic compounds and has been shown for the phenol-degrading strain Pseudomonas 
putida S12 (Isken S, Derks A, Wolffs PFG, et al., 1999).
Cis- to trans- isomerisation of fatty acids is a method of adapting cell membranes to toxic 
solvents that do not occur in the natural environment. In the presence of phenols P . putida 
P8 was found to adapt by altering the proportion of cis and trans isomers of fatty acids 
(Loffhagen N, Hartig C, & Babel W, 2001). It remains to be seen if the partition 
coefficient of the solvents is strongly affected by the composition of the membrane.
Solvent tolerant organisms could be used in the field of biocatalysis. The use of organisms 
with complete tolerance to solvents with a low solubility in water such as toluene, styrene, 
tetralin and terpenes will promote the application of whole cells in such systems. This will 
reduce the cost of biocatalysis that require cofactors such as NAD and ATP (Section 2).
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1.5 Solvents as anaesthetics
An examination of the effect of solvents on whole cells has shown that the Log P value is 
useful in determining toxicity. This can be related to the solubility in biological 
membranes, but for some molecules this correlation breaks down (Antunes-Madeira & 
Madeira, 1989). An understanding of the interaction of organic solvents with biological 
membranes is important in the field of anaesthesia where organic solvents can be 
described as anaesthetic like molecules. This section introduces the lipid theory of 
anaesthesia. The problems with this theory and the possible solutions are discussed below.
1.5.1 Meyer and Overton
In the 1890s Hans Meyer and Ernst Overton showed that the potency of anaesthetics 
increased in proportion to its olive oil water partition coefficient (Equation 1-3), 
(Seeman, 1972)
P  =
'{Solute,L  NI olive o il
k [Solute]
anesthetic potency
Equation 1-3 Partition coefficient P, of a given compound in the standard 
octanol water two-phase system.
A better correlation of anaesthetic potency with solubility was achieved with an octanol 
water system (Franks & Lieb, 1982). A double log plot of potency in the aqueous phase 
and the octanol water partition coefficient yields a straight line with unit slope (Franks & 
Lieb, 1982). The anaesthetic site has similar characteristics to octanol and anaesthetic 
potency can be predicted from Log P. Although the site is amphiphilic, having both 
hydrophilic and hydrophobic properties, and the interaction is less affected by the size, 
shape or chemical characteristics of the solvent.
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1.5.2 What is the target for anaesthetics?
Since Meyer and Overton discovered a correlation between the anaesthetic potency of 
simple molecules and partitioning into fat-like solvents, the traditional view has been that 
anaesthetics act by disrupting the bulk structure of the lipid portions of nerve membranes 
(Janoff, Pringle & Miller, 1981).
The lipid properties that are modified differ from theory to theory and include volume 
expansion (Richards, 1980), increasing membrane fluidity (Franks & Lieb, 1982), 
increasing membrane thickness (Haydon et al., 1984), increasing membrane surface 
tension (Miller, 1985), and creating polar dislocations in lipid bilayers (Bangham and 
Hill, 1986). The effect of anaesthetics on these membranes has been shown to be very 
small and can be reproduced by a small (1 °C) change in temperature. This evidence lead 
to a new hypothesis that it was the boundary lipids surrounding membrane proteins that are 
preferentially affected (Franks & Lieb, 1984). However recent work suggests that this is 
not correct (Abaji et al., 1993).
Most anaethetic drugs whose mechanisms have been established are know to act by 
binding directly to proteins. Evidence that general anaesthetics might also act in this way 
came with the demonstration that the activity of a soluble lipid-free enzyme, firefly 
luciferase, could be inhibited by a wide range of anaesthetics at IC50 concentrations very 
close to animal EC50 values. These observations are not only evidence for the protein 
binding mechanism of anaesthesia, but provide a simple explanation to the Meyer-Overton 
correlation in the form of anaesthetic binding sites (Franks & Lieb, 1986).
1.5.2.1 Molecular cut off effect
Although anaesthetic potency increases with Log P, there is a size limitation. This is 
demonstrated by the so-called cut-off effect (Franks & Lieb, 1986). As a homologous 
series of anaesthetics is ascended, aqueous phase potencies increase until they become 
totally ineffective anaesthetics (Pringle et al., 1981). One explanation for this finding is 
that the site has a finite size and simply excludes large molecules. This can account for the 
inactivity of dodecanol relative to tetradecanol. The cut off effect can be most simply 
explained by anaesthetics binding to protein pockets or clefts with fixed dimensions 
(Franks & Lieb, 1993). Explanations in terms of lipid theory have been more difficult to 
accommodate. It was suggested (Seeman, 1972) that the solubility of long-chain alcohols
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was simply not sufficient in bilayers, but this has been shown to be an incorrect assertion 
by experiment (Franks & Lieb, 1991).
Evidence that the mechanism of anaesthesia is via direct protein interactions comes from 
studies with chiral anaesthetics. These compounds show no stereospecific effect on bulk 
lipid bilayers but are stereospecific with respect to their anaesthetic abilities (Franks & 
Lieb, 1991).
The current evidence (Franks & Lieb, 1991) indicates that general anaesthetics act by 
binding directly to proteins.
It is also suspected that the binding sites of these proteins are hydrophobic pockets 
exposed to water rather than interfacial sites exposed to lipid hydrocarbon chains. Water 
filled pockets might be expected to bind hydrophobic anaesthetics more tightly. It is 
generally agreed that the ultimate target of anaesthetics is a membrane protein even if the 
interaction is mediated by the lipid bilayer. In the next section, the different possible 
protein targets are discussed effect (Franks & Lieb, 1987).
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1.6 Protein target of anaesthesia
It is known that anaesthetics act by selectively targeting synaptic ion channels or the 
systems that regulate them (Miller, 2002). Their action at the molecular level however 
remains uncertain. There are two sites that have been promoted as a possible receptor for 
anaesthetic molecules: proteins and lipids (Sureda & Mallol, 2003).
The effects of anaesthesia on the central nervous system (CNS) have been explored over 
the last decade and these studies have focused largely on nerve membranes, and in 
particular on neuronal ion channels and the systems that regulates them. Current evidence 
suggests that the anaesthetic effect originates from an alteration in synaptic or axonal 
transmission. A synaptic target could be either pre or post-synaptic and the effect of 
anaesthetics on synaptic sites could be to stimulate inhibitory synapses or inhibit excitatory 
synapses. An important question that remains unanswered is the molecular effects of 
anaesthetics, whether they perturb membrane lipids or as evidence that is more recent 
indicates, bind directly to membrane proteins (Sureda & Mallol, 2003).
1.6.1 The effect of anaethetics on Voltage-gated ion channels
Voltage-gated ion channels are regulated by changes in membrane potential and include 
Na+, K+ and Ca2+ channels.
1.6.1.1 The effect of anaethetics on Na+ and K* channels
The interactions of many simple organic compounds with the Na+ and K+ channels 
involved in the generation of an action potential have been described for the squid giant 
axon (Elliot & Haydon, 1989). At physiologically relevant concentrations however, both 
the Na+ and K+ channels are insensitive to solvents and axonal conduction is unaffected at 
anaesthetic concentrations.
Voltage-gated Na+ or K+ channels, appear unlikely candidates for major anaesthetic targets 
(Elliot & Haydon, 1989).
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1.6.1.2 Ca2+channels
*yt
Voltage-gated Ca channels (T, L, N and P) share sequence homology with voltage gated 
Na+ and K+ ion channels and are members of the same super-family. N and P type 
channels are found mainly in neurones and these appear to be most directly involved in the 
pre-synaptic release of neurotransmitters from control nerve terminals (Takahashi & 
Momiyama, 1993). The effects of volatile anaesthetics have been extensively investigated 
and most studies show that these channels are extremely insensitive to these agents 
(Franks & Lieb, 1993). Barbiturates have been shown to inhibit Ca2+ channels, but 
usually with half-maximal inhibitory concentrations (IC50) more than three fold in excess 
of the free aqueous concentrations that cause general anaesthesia (Nishi & Oyama, 1983). 
In summary, voltage gated Ca2+ channels appear to be generally insensitive to clinically 
used anaesthetics.
1.6.2 Ligand-gated ion channels
Ligand-gated ion channels respond to binding of a specific molecule and include 
glutamate, nicotinic acetylcholine, and GABAa receptors (Harrison, et al., 1997).
L-Glutamate is probably the major excitatory neurotransmitter in the vertebrate CNS. 
There have been few modem studies with clinical general anaesthetics on its ionotropic 
receptor channels (iGluRs), which mediate fast excitatory transmission. They are 
classified by their selective agonist NOMAD (V-methyl-D-aspartate), KA (Kainate), and 
AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazolepropionoic acid). Ketamine has been 
shown to exert its anaesthetic effect by inhibiting the NOMAD receptor. The NOMAD 
receptor contains at least five distinct sites and is opened when occupied by an agonist,
2 j |
such as NOMAD. When open it allows an influx of Ca and Na into the cell. In 
contrast, to ketamine all volatile agents are ineffective at modifying the iGluRs to give any 
anaesthetic effect (Wakamori et al., 1991).
The nicotinic acetylcholine receptor (nAChR) of the neuromuscular junction is the most 
thoroughly studied of all neurotransmitter receptors. It has been shown that the simplest 
anaesthetics at high concentrations can stabilise a desensitised form of the receptor. At 
relevant doses however other effects are observed that vary between agents. Among the 
volatile anaesthetics the fluorinated ethers isoflurane and enflurane are particularly
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effective at inhibiting the receptor, with the primary effect at the single-channel level being 
to reduce the mean open time (Yushmanov, et a/.2003).
Intravenous agents, barbiturates, and short chain alcohol’s have been shown to; increase 
the decay rate of miniature endplate currents, reduce single channel mean open time in 
denervated rat skeletal muscle (Dilger et al., 1992), and inhibit nerve response to stimulus 
respectively.
Although nAChRs are sensitive to a number of different anaesthetics, it is not clear yet that 
how their inhibition contributes to general anaesthesia?
General anaesthetics may act by potentiating inhibitory synaptic transmission, and the 
GABAa receptor channel has been considered a potential target. GABA (y-aminobutyric 
acid) is the most important inhibitory neurotransmitter in the brain and most anaesthetics 
are very effective at potentiating responses to GABA. The major action of pentobarbital 
and most other anaesthetics is to shift the GABA response curve to lower concentrations, 
so peak Cl" currents elicited by high levels of GABA are virtually unaffected. Anaesthetics 
tend to enhance and hence prolong receptor binding of GABA released pre-synaptically 
from vesicles in brief but high concentration pulses.
Single channel studies with volatile agents (Yeh et al., 1991); barbiturates and propofol 
(Hales & Lambert, 1991) show no changes in channel conductance, but the channel open 
time increases, consistent with the prolongation of post-synaptic currents. Thus the 
molecular basis for the potentiation of GABA action by anaesthetics is an increased 
probability for the GABAa receptor channel to be in the open state. The extent to which 
this is due to enhanced GABA binding, or to changes in channel gating, remains to be 
determined and may depend on the anaesthetic.
Generally almost all agents at their half-maximal effective concentrations EC50 enhance 
the current induced by low levels of GABA by over 50 %. Although uncertainties remain 
as to the extent to which intact GABA synapses are functionally potentiated, there is now 
an impressive body of evidence that points to the GABAa receptor channel complex as a 
major target for most general anaesthetics. If this is a direct effect on the ion channel or an 
indirect effect through an action on the membrane is yet to be determined.
43
1.6.3 Other inhibitory ion channels
Whereas GABA is the most important neurotransmitter in the brain, glycine plays a major 
role in the spinal cord and lower brainstem. However, no comprehensive anaesthetic 
studies have been carried out on the glycine receptors.
Inhibitory synapses are also candidates for explaining the well-known pressure reversal of 
general anaesthesia. For example, the effects of pressure resemble those of strychnine 
(Boser-Riley, Daniels & Smith, 1988), a glycine antagonist. As pressure almost 
invariably depresses synaptic transmission in vitro, pressure reversal could, in principle, be 
explained by pressure blocking inhibitory synapses, but there is now less conviction that 
pressure reversal will provide fundamental clues as to how anaesthetics act. The 
phenomenon of pressure reversal may prove to be incidental to the mechanisms of general 
anaesthesia.
1.6.4 Synaptic target
Although it is clear that anaesthetics can have substantial affects on post-synaptic 
membranes, the extent to which they act pre-synaptically is difficult to assess. Studies 
(Takenoshita & Takahashi, 1987) suggest that at relevant concentrations of halothane 
and thiopental neurotransmitter release might be inhibited by about 20 %. As a whole, it is 
likely that some anaesthetic inhibition of transmitter release occurs at many synapses, 
although the effects are small.
1.6.5 Second messenger systems
Second messengers regulate the activity of many enzymes and ion channels, sometimes by
9 +direct binding but more often by phosphorylation. Free intercellular Ca is an important 
second messenger and it has been thought that anaesthetics might disrupt neuronal 
function by increasing its concentration. It has been shown however, that there is no
94-significant sustained effect on resting intracellular Ca at anaesthetic concentrations 
(Daniell & Harris, 1988). The inhibitory effects have also been ascribed to blocking of 
voltage-gated or receptor-operated Ca2+ channels, inhibition of inositol triphosphate 
(InsP3) production or depletion of internal Ca2+ stores.
44
Another branch of the phosphadyl inositol second messenger pathway produces 
diacylglycerol, which activates protein kinase C (PKC). The effects of anaesthetics on 
diacylglycerol production are not known to date, but its PKC target can be inhibited by 
anaesthetics. Liver cytochrome P450-mediated metabolism of arachidonic acid, an 
eicosanoid second messenger that can also be derived from inositol phospholipids, is 
inhibited very selectively by a wide range of anaesthetics. There is little hard evidence that 
second messenger systems are involved in general anaesthesia. At high enough 
concentrations anaesthetics can substantially affect many second messenger systems but 
the few studies made at relevant concentrations suggest that they may be relatively 
insensitive to anaesthetic perturbation.
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1.7 Cytochrome P450
Cytochrome P450 superfamily is widely distributed in animals and plants. There is 
perhaps no better example of the exploitation of the heme cofactor for such an abundant 
variety of chemical reactions than the P450 cytochromes (P450s). These enzymes use the 
same basic construction and chemistry to catalyse a wide variety of reactions of an 
enormous library of chemicals. Among the many types of chemical reactions catalysed by 
the P450s are hydroxylation, epoxidation, dehydrogenation, sulphoxidation, 
dehalogenation and N-, S- and O-dealkylation. P450s can also catalyse reduction of e.g. 
alkyl halides, and nitric oxide, isomerisation of prostaglandin H2 (Hecker et al,, 1989), 
and dehydration (Song & Brash, 1991).
Many aspects of this research on these enzymes have strong medical implications. For 
instance, many prescribed drugs are metabolised by the hepatic P450 systems and may also 
act as inducers of the production of the relevant isoforms (usually at the gene level). 
Barbiturates are a classic example of the P450 induction phenomenon (Alterman et aL, 
1995). Analysis of the P450s and their substrate specificity profile is central to the 
comprehension of the efficacy and safety of numerous drugs. The basic roles of the P450s 
in human metabolism are still being deciphered and the means by which the P450s are 
regulated (at both the gene and protein level) is of major importance. A very large number 
of human P450s are involved in steroid metabolism and are subject to regulation by 
hormones. An example of which is the adrenal gland mitochondrial P450scc which 
catalyses the oxidative cleavage of the cholesterol side chain to produce pregnenolone. 
This is the initial step in the mammalian steroid synthesis pathway (Hanukolglu, et al,, 
1993).
Since the discovery of the first P450s there has been a large increase in the number of 
P450s identified. Multiple membrane-bound forms have been identified from eukaryotic 
sources and a wide range of important biological functions are attributed to them including 
human liver isoforms, the oxidation of numerous drugs (including ibuprofen, codeine and 
caffeine), the interconversion and metabolism of steroids (Park, et a l, 1995). An increase 
in the exposure of mammals to drugs and other environmental xenobiotics occurred over 
the last 50 years, and the P450s played an important protection role against these
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compounds. The multiple forms of mammalian P450s have a wide and often overlapping 
substrate specificity profile. The oxidation of the xenobiotic materials catalysed by P450s 
generally results in an increase in the hydrophilicity of these compounds. The reaction 
also facilitates their excretion into the aqueous solutions of urine and/or bile. The P450s 
can transform otherwise inert chemicals into highly reactive and possibly 
mutagenic/carcinogenic derivatives, e.g. the biotransformation of benzo-a-pyrene, a 
relatively inert component of cigarette smoke, into a carcinogenic epoxide derivative 
(Hadley et al., 1982). The arrival of gene sequencing techniques 20 years ago led to the 
accumulation and comparison of P450 amino acid sequences. In recent years, improved 
techniques for gene isolation and characterisation as well as genome sequencing projects 
have provided a comprehensive databank of P450 sequences for analysis. The P450s have 
been organised into an enzyme superfamily with divisions into families based on protein 
sequence homology. Within the superfamily, members of the same family generally share 
>40 % identity with one another and members of the same sub-family show even stronger 
identity. The number of sequences documented now exceeds 500 (Nelson et a l , 1996). 
Clearly, a great deal of protein chemical, structural and enzymological characterisation 
remains to be performed with the majority of the P450 enzymes. The vast numbers of 
P450s in certain species is an indicator of the versatility of their chemistry and of their 
importance to the survival of higher organisms. Analysis of P450 evolution through 
amino acid sequence alignments suggests that fatty acid metabolising forms were among 
the earliest to develop. The fact that P450 has been discovered in archaebacteria, ancient 
organisms, indicates that P450s may have served useful roles in very early life forms.
1.7.1 Oxygen activation
Most of the biochemical transformations catalysed by the P450s result from an initial 
substrate monoxygenase reaction and the chemistry of oxygen activation catalysed by the 
P450s has always been a topic of great intrigue. The process can be described using 
P450cam as the model system. The heme iron of P450 is ligated by a cysteine as the fifth 
ligand. The sixth position is left vacant for ligation of oxygen during catalysis, but may be 
occupied by a water molecule in the resting state. Substrate binding to the P450 provides 
the starting point for the monooxygenase cycle. The heme iron is ferric and low-spin (S = 
1/2) until binding of camphor. Thereafter, active site water is displaced by the substrate
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and the iron becomes high-spin (S = 5/2). Associated with the spin-state shift is an 
increase in the redox potential of the heme (from approx. 300 mV to -170 mV). The redox 
potential shift permits one electron reduction by reduced putidaredoxin (Sligar, 1974). 
Oxygen then binds to the ferrous heme iron, forming a ferrous-superoxide species referred 
to as "oxyP450" (Sligar, 1974). The delivery of a second electron to the heme (also from 
putidaredoxin) precipitates an extremely rapid substrate oxygenation process, the 
mechanism of which is still the subject of some controversy. A likely mechanism involves 
reduction to a ferric-peroxy species, which may also exist in a ferrous-superoxide form. 
The subsequent delivery of two protons to the reaction centre results in the loss of one 
atom of oxygen in the formation of a water molecule and the production of a transient 
high-valent ironoxo species. This is often presented as [FeO]3+, but may be stabilised 
through a number of resonance structures. The abstraction of a hydrogen from the 
camphor results in formation of a substrate radical that collapses via an oxygen rebound to 
generate a ferric enzyme-product complex. Dissociation of the 5-OH camphor returns the 
P450 to its resting state. The ability of the P450s to catalyse the oxidation of both 
NAD(P)H and substrate explains their older title of mixed function oxidases. While 
P450cam remains the most intensively studied of all the P450s, there has also been 
intensive research on the P450 BM3 system over the last decade. The P450 BM3 system 
may provide an experimentally tractable model for the entire class IIP450 electron transfer 
chain (diflavin P450 reductase and P450) in a single polypeptide. At 119,000 Da, the fatty 
acid hydroxylase P450 BM3 is the largest P450. It also has the highest catalytic centre 
monooxygenase activity of any P450 - with rates of up to 4600 min"1 reported for the 
oxidation of favoured substrates. While P450 BM3 will hydroxylate fatty acid of a variety 
of chain lengths, optimal activity is towards C l5 and C16 molecules. Oxidation occurs 
near the terminal of the molecules. The co-2 position is usually favoured, but oxidations 
can also occur at o l  and co-3 (Miura & Fulco, 1986).
1.7.2 Role in detoxification
Many eukaryotes and bacteria respond to the presence of a P450 substrate by inducing the 
production of the P450 responsible for its catabolism at the gene level. These response 
mechanisms provide organisms with the ability to cope with novel exposure to an array of 
xenobiotics and to changes in the concentrations of endogenous biochemicals. The
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mammalian microsomal P450s are a first line defence mechanism for higher organisms, 
playing a vital role in the conversion of xenobiotic toxins. Many microorganisms have 
taken this a step further, utilising the P450s in metabolic pathways for the assimilation of 
energy contained within unusual carbon sources (Sanglard & Loper, 1989).
P450s are b-type cytochromes, which derive their title from the absorbance peak 
associated with their carbon monoxide-bound ferrous forms (Poulos et a l, 1995). The 
unusual absorbance properties derive from an iron-sulphur bond (through a conserved 
cysteine residue) which anchors heme into the active sites of the enzyme. While there is 
much variation in the amino acid sequences available for the P450s, the known structures 
exhibit significant similarity - all are a-helix rich constructions resembling triagonal 
prisms. The P450s have the ability to bind and activate molecular oxygen, breaking the 
dioxygen bond and catalysing the insertion of a single atom of oxygen into a wide range of 
organic molecules, often with high stereo- and regio-specificity. A vast number of P450s 
have been characterised at the DNA level, with partial and total nucleotide sequences (and, 
hence, translated amino acid sequences) for well over 300 forms identified by 1993 
(Nelson et al., 1993).
1.7.3 Origins of cytochrome P450
The ancestral gene existed more than 3.5 billion years ago, predating drugs and animal- 
plant interactions by at least 1 billion years. An early role for oxidative enzymes in 
prokaryotes most likely involved energy substrate utilisation: insertion of oxygen into 
various inaccessible forms of carbon and other food sources, thereby rendering them 
accessible to further metabolism. It has also been proposed that the P450 enzymes, as well 
as other 'drug metabolising' enzymes, play an important role in maintaining the steady state 
levels of endogenous ligands involved in ligand modulated transcription of genes effecting 
homeostasis, growth, differention, and neuro-endocrine functions (Nebert, 1991).
1.7.4 Characterisation
Due to the inherent difficulties in purifying and working with membrane-bound enzymes, 
fewer have been characterised at the enzyme level. However, the bacterial forms of P450 
are all soluble enzymes and are more amenable to purification and characterisation by
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protein, chemical and spectroscopic techniques. Most of our understanding of P450 
structure and function has been deduced through studies of the bacterial forms.
Four P450 atomic structures have been solved to date, all of which are from bacterial 
sources. The first structure, the camphor hydroxylase P450cam from Pseudomonas was 
reported in 1987 (Pooulos, Finzel & Howard). In 1993, the structure for the fatty acid 
hydroxylase P450 BM3 from Bacillus megaterium was reported (Ravichandran et al 
1993). The structures of P450(terp), (Hasemann et al,, 1994) and P450eryf 
(Cuppvickery & Poulos, 1995) have also been solved.
1.7.5 Classification by redox partner
The cytochromes P450 can be divided into two classes, depending on the nature of their 
redox partners, which provide them with the two successive one-electron transfers 
required for their catalytic process.
1.7.5.1 Class I
Class I enzymes are the terminal oxidases of a 3-component electron transfer chain and are 
typified by the mammalian adrenal mitochondrial steroid hydroxylases and all but one 
bacterial form. The P450 is reduced by a small iron sulphur protein (ferredoxin) which, in 
turn, is reduced by an NAD(P)H-dependent FAD-containing ferredoxin reductase (Munro 
& Lindsay, 1996).
1.7.5.2 Class 11
The mammalian hepatic drug-metabolising forms typify class II P450s. In these cases a 
single FAD and FMN containing enzyme (an NADPH-cytochrome P450 reductase) 
catalyses electron transfers to the P450 (Harikrishna, 1993). The cytochrome P450 BM3 
from B. megaterium ATCC 14581, is the only example of a bacterial class II P450. This 
cytochrome P450 is interesting since it is reduced by a eukaryotic-like P450 reductase that 
is fused to the P450 in a single polypeptide (Narhi & Fulco, 1987). In both classes of 
cytochromes the order of electron flow is NADPH -> FAD -> FMN -> heme.
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1.7.6 Classification by solubility
Another method of classifying the P450s is based on the solubility. All the prokaryotic 
members of the P450 superfamily are soluble and can be maintained in aqueous solution at 
high concentrations. Eukaryotic forms are generally associated with cell membranes via 
hydrophobic interactions at the N-terminus of the enzymes that are critical for activity. 
However, it has been reported recently that the soluble eukaryotic forms can be found in a 
yeast (Nakayama et al., 1996) and in a plant (Schuler, 1996).
1.7.7 Future for P450s
Future prospects for the study of the P450s seem interesting. Mammalian cell lines 
expressing different P450 isoforms are being developed as an advanced means of 
screening novel drugs. While overexpression of membranous proteins is notoriously 
difficult, great successes have been made for a number of mammalian P450s, through re­
design of their N-terminal amino acids (Fisher et al., 1992). Biotechnological interest is 
high in the use of bacterial forms for degrading organic pollutants and there has already 
been major investment in the use of yeast P450s for steroid synthises. It has also been 
shown that electrical currents can be used to turn over P450 enzymes into a productive 
catalytic cycle (Faulkner et aL, 1995).
With their wealth of roles and applications in biological and chemical fields, the P450s are 
certain to remain a major focus of interest in academic and pharmaceutical research, well 
into the next century. Their range of catalytic actions, their association with cellular 
membranes, and their current role in oxidative catalysis in the pharmaceutical industry, 
made this group of enzymes a suitable target for a study of the effect of solvents on 
biotransformations.
1.8 Rational for experimental programme
1.8.1 Solvents and membrane proteins
Solvents can affect the catalytic ability of proteins both by inhibition and by modification 
of global stability (Klibanov 1986). They can also act as general anaesthetics by 
dissolving in to lipid membranes and affecting synaptic ion channels or their regulatory
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systems. The anaesthetic potency of a molecule and its toxicity can be determined to some 
extent by its log P value.
Little work has been documented linking the toxicity or anaesthetic potency with actual 
concentrations of solvent that partitions into the membrane from the aqueous or gaseous 
phase. This reflects the difficulty in working with membrane bound proteins.
The solvent effects on progesterone lla-hydroxylase activity in Rhizopus stolonifer have 
however been documented using aqueous two phase systems (Ceen et al., 1987; Osborne 
et aL, 1990). The progesterone lla-hydroxylase system consists of two enzymes that 
function to hydroxylate the C-l l  of progesterone. The microbial hydroxylation of 
progesterone carried out in an aqueous environment yields low productivity due to the low 
solubility of both the substrate and the product. Ceen et al., (1987), used an 
organic/aqueous two phase system to increase the concentrations of the substrates and the 
products, but this had an adverse effect on the activity of Aspergillus ochraceous. The use 
of long chain fatty acids however increased the stability and productivity over 
conventional aqueous media.
Osborne (1990) used Rhizopus stolonifer as a packed bed bioreactor and presented a 
detailed study of the factors that caused the loss of activity. They showed a high 
correlation between the loss of activity and the concentration of organic solvent that 
partitioned into the cell membranes as calculated by log P values. However, the initial 
effects of solvents on the rate of the hydroxylation were not measured. Inhibition of the 
reaction was recorded after a 24 hr incubation period. The distinction between inhibition 
of the hydroxylation and the stability of the fungi was not drawn.
1.8.1.1 The volume occupancy hypothesis
By modification of the Collander equation, they were able to show that the total loss of 
activity occurs at a single critical membrane solvent concentration irrespective of the type 
of organic solvent. Organic solvents unable to achieve this critical membrane 
concentration were shown to allow the retention of hydroxylase activity at saturating 
aqueous phase concentrations. However, with the development of a discrete second 
organic phase loss of activity occurred through so termed 'phase' effects (Osborne, 1990). 
If the effects of the second phase were removed then this hypothesis links well with the
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low solubility theory to explain the molecular ‘cut o ff effect in anaesthesia (Pringle et al., 
1981). What all ‘cut o ff molecules have in common is a low solubility in the aqueous 
phase. So that even in equilibrium it is impossible, in principle, to deliver enough drug to 
the site. Also, the final equilibrium concentration at the site must be independent of the 
path. So that even if in theory the equilibrium concentration of solvent in the membrane is 
high enough the rate of the transfer may be limiting so that in practice the solvent is 
inactive as cellular toxin or anaesthetic. This hypothesis in relation to anaesthesia is 
extremely similar to the hypothesis described some time later by Osborne, 1990.
1.8.1.2 How do solvents deactivate membrane proteins?
Membrane proteins such as P450 hydroxylase enzymes were shown to be inhibited at 
certain volume occupancy by calculation from log P values (Ceen et al.f 1987; Osborne et 
al., 1990). However, no exact experimental determination of solvent concentrations 
associated with the membrane was carried out. In this study, a method to determine 
experimentally the exact concentration of solvent associated with the membrane and the 
inhibition of membrane proteins with actual concentrations of solvent that is intimate with 
protein and membrane will be developed.
To test the hypothesis an accurate measurement of solvent that is associated with the 
membrane phase is required. In the next section, the problems with this measurement and 
solutions are described.
1.8.2 Determination of Solvent Concentration
There is no accurate and reliable method for directly measuring solvent concentrations 
associated with biological membranes. However, methods for the routine detection and 
measurement of solvents in aqueous solutions are available. If we add a known volume of 
solvents to a mixture of membrane and water, and we have a method of measuring the 
concentration of solvent in the aqueous phase then by difference we can determine the 
concentration of solvent associated with the membrane.
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1.8.2.1 Methods of aqueous solvent detection
Traditional methods include both gas chromatography and radio labelled solvent (Sallee, 
1978). Recent developments in the field of optical biosensors have produced detection 
methods for methanol in hydrocarbon mixtures (Hubert et al., 1995).
Both traditional and current techniques do not distinguish between solvent that is 
associated with the organic phase. These techniques rely on the total separation of 
membrane from the aqueous phase. This is technically difficult and failure to complete the 
process of separation results in high overestimation of the concentration of solvent, since 
hydrophobic organic molecules will tend to partition into the membrane. The presence of 
very small amounts of water-soluble impurities can produce large overestimates of solvent 
concentrations.
1.8.2.2 Luciferase as a method of solvent detection
Franks and Lieb investigated the hypothesis that anaesthetics act directly on membrane 
proteins and that the regulation is not mediated by the cellular membranes (Franks & 
Lieb, 1982). They used purified luciferase from the North American firefly P. pyralis 
(Franks & Lieb, 1984). In their studies they employed the luciferase enzyme to report on 
the solvent of the aqueous phase. They showed that the concentration of solvents needed 
to inhibit the enzyme by 50 % was of the same order as the concentration required to 
anaesthetise animals. They also reported that luciferase was unaffected by cell membranes 
(Franks & Lieb 1986). The inhibition of the bioluminescent light reaction could be used 
to measure partitioning of alcohols into lipid bilayers.
1.8.2.3 Bioluminescence as a solvent detection method
When luciferase and D-luciferin react in the presence of oxygen ATP and magnesium ions 
a flash of light is emitted. When exposed to various lipophilic solutes, in buffer or in 
equilibrium with membrane suspensions the flash response is inhibited. By measuring the 
inhibition with and without membrane Franks and Lieb were able to calculate the 
membrane /buffer partition coefficient directly knowing only the volumes of buffer and 
membrane and; the initial amount of solvent added to the suspension.
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This is possible because luciferase unlike previous methods only reports on the solvent in 
the aqueous phase. The inhibition of luciferase enables the detection of aqueous solvent 
without the removal of membrane. Errors due to minute amount (<0.01%) of membrane 
therefore do not arise. Also because inhibition is proportional to lipid solubility (Franks 
& Lieb, 1984), water-soluble impurities that overestimate the concentration in the 
radioactive tracer techniques do not give rise to errors (Franks & Lieb, 1986).
1.8.2.4 The luciferase reaction
The luciferase enzyme from the North American firefly Photinus pyralis can be purified 
using affinity chromatography to the crystalline protein, free of the substrate luciferin.
i
Firefly luciferase combines with luciferin (RMM 280) in the presence of ATP, Mg and 
O2, to give a photon of light, (Figure 1-5). When the reactants are rapidly mixed, an 
initial burst of light is followed by a slow decay. The maximum rate of light production is 
sensitive to the presence of anaesthetics such that the decrease in the initial rate of reaction 
can be correlated with the concentration of solvent.
1.8.2.5 Inhibition of luciferase
In order to test the hypothesis that general anaesthetics act directly on protein, Franks and 
Lieb studied luciferase free from any lipid, so that any effects observed could be 
interpreted in terms of anaesthetic-protein interactions Franks and Lieb (1984). They 
showed that the maximum rate of light production was sensitive to the presence of 
anaesthetics and that there was a high correlation between the concentration of anaesthetic 
needed to inhibit the enzyme by 50 % (IC50) and whole animal potencies (reciprocals of 
aqueous ED50 concentrations) over a 100,000 fold range.
1.8.3 A suitable membrane enzyme
For further examination of the molecular target of anaesthesia and the effects of solvents 
on membrane proteins, a membrane protein that can be readily assayed for its activity must 
be obtained. The membrane bound protein must not be part of a metabolic pathway since 
we would like to determine the effect of solvents on that protein only. If the product is 
metabolised a recording of the rate reaction will be difficult and the accuracy will be 
dependent on the relative rates of processes before and after the reaction of interest. A
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membrane protein that metabolises excreted waste products is one option. The 
cytochrome P450 monooxygenase proteins are an example of drug metabolising enzymes. 
To separate the effect of the membrane on the reaction a soluble P450 for control is also 
required.
COOH
Luciferin (LH2)
luciferase
HO HOCOOH
light
Figure 1-5 Luciferase catalysed oxidation of luciferin
Methanol, ethanol, acetone, H-propanol, butanone, paraldehyde, diethyl ether, w-butanol, 
toluene, chloroform, w-hexanol, halothane, w-octanol, pentane, rc-nonanol, hexane, and n- 
decanol were used as anaesthetics in the investigation.
1.8.3.1 Cytochrome P450 11a
Osborne (1990) investigated the effects of alcohols on the lla-hydroxylase system from 
Rhizopus stolonifer. This steroid hydroxylating enzyme catalyses the conversion of 
progesterone to 1 la-hydroxyprogesterone, (Figure 1-6).
The growth and induction of the organism have been investigated (Hanisch 1978, 
Osborne, 1990). Cell free extracts of R. stolonifer showed that the hydroxylase system is 
located in the microsomal fraction of the cytoplasm and involvement of the cytochrome 
P450 system is indicated in the reaction (Osborne, 1990).
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To test the hypothesis at least one membrane bound hydroxylase enzyme system is 
required. This can be obtained from R. stolonifer in the same way as Osborne (1990).
CH
HO
R. stolonifer
Progesterone 1 la-hydroxyprogesterone
Figure 1-6 Conversion of progesterone to 1 la-hydroxyprogesterone by 
whole cells of R. stolonifer.
1.8.3.2 A soluble P450
To determine if the membrane plays a role in the interaction of solvent and protein we will 
require an enzyme of similar activity that is readily soluble and can be removed from all 
membranes in an active state. Cytochrome P450 BM3 from Bacillus megaterium satisfies 
these criteria and therefore we will look for a family of P450 type enzyme systems to 
investigate if the hypothesis holds for all or any of the membrane proteins. P450 enzyme 
systems are also extremely important enzymes since they function to hydroxylate a wide 
range of xenobiotic compounds.
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2. Aims of the thesis
Previous work has demonstrated a correlation between Log P values and the inhibition of 
the membrane bound cytochrome P450 in R. nigricans, which hydroxylates the 11a 
portion of progesterone (Osborne et al, 1992).
The suggestion was made that this correlation in fact reflects a critical molar concentration 
of solvent in the membrane at which the enzyme is inhibited, and which is the same for 
any one of a homologous series of solvents (Osborne et al, 1992).
The correlation between an anaesthetic effect and a critical solvent concentration in 
biological membranes is one of long standing in the studies of general anaesthesia 
(Seeman, 1972). An assay developed for the use in these studies (Franks and Leib, 
1984) is appropriate for measuring the aqueous solvent concentrations, which inhibit 
cytochrome P450 hydroxylases, and this is the starting point for this thesis, which aims.
1. To set up an assay to measure the equilibrium concentration of a solvent in the aqueous 
phase of a suspension of biological membranes derived from microbial cells. An assay 
based on the inhibition of luciferase, (Franks and Leib, 1986) is known to do this, but it 
must be modified to work with equipment available in the Dept, of Biochemical 
Engineering.
2. To compare the effect of organic solvents on a soluble and on a membrane bound 
cytochrome P450 hydroxylase in a manner which relates Log P value of the solvent to the 
actual concentration of solvent in the aqueous phase, rather than to the total concentration 
of solvent in the system. The soluble cytochrome P450 is derived from B. megaterium 
and it hydroxylates fatty acids. The membrane bound enzyme is the progesterone 11a 
hydroxylase derived from R. stolonifer (formally called R. nigricans).
3. To test the suggestion that a membrane bound enzyme is inhibited when the solvent 
concentration in the membrane exceeds a critical value, and that this is the primary effect 
in the link between the Log P or a solvent and its inhibition of enzyme activity.
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4. To show how small differences between enzymes in any link between the Log P of a 
solvent and its inhibition might be reliably determined as the basis of developing 
incremental improvements in the resistance of enzymes to organic solvents.
2.1 Layout of Experimental sections
Section 3 describes the development of the luciferase assay of the aqueous solvent 
concentration.
Section 4 describes Isolation of P450 BM3 from B. megaterium.
Section 5 describes how P450 BM3 was isolated from E. coli.
Section 6 describes the effect of ^ -alcohols on the activity of cytochrome P450 BM3. 
Section 7 investigates the hydroxylation of progesterone by whole cells of R. stolonifer. 
Section 8 Inhibition of whole cells of R. stolonifer with w-alcohols.
Section 9 investigates the partitioning of solvents into whole cells of R. stolonifer
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3. Development of a solvent biosensor based 
on firefly luciferase
The use of firefly bioluminescence to measure ATP derived from living biological material 
is now generally accepted and is the basis of numerous commercial products. The general 
principles of the light production and its measurement are well understood (Section 1). 
This section of the thesis describes how the firefly light producing reaction, that is 
catalysed by the enzyme luciferase (EC 1.13.12.7), (Equation 3-1) was developed into a 
solvent biosensor in the presence of other biological material, using existing equipment 
available in the Dept, of Biochemical Eng.
Luciferin + O2 + ATP —>—> oxyluciferin +ADP +PPi + CO2 + Light at 562 nm
Equation 3-1 The bioluminescent reaction of luciferase
Firefly luciferase has been shown to report on only the solvent associated with the aqueous 
phase (Franks & Lieb, 1984). The flash kinetics associated with the luciferase-luciferin 
reaction (Figure 3-1) must be modified for an accurate and reproducible assay that does 
not change significantly with the time of measurement.
In its final form the solvent biosensor was stable, simple to use, and gave an accurate 
estimate of the aqueous concentration of a range of alkanes and primary alcohols.
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Figure 3-1 Comparison of flash emissions of the luciferase - luciferin 
reaction.
( • )  Franks & Lieb, 1984, ( H ) the desired kinetics.
This chapter is divided into five sections.
Section 3.1 The selection of equipment suitable for measuring the light output from the 
luciferase assay.
Section 3.2 The measures used to stabilise the light output from the Enzymatix ATP kit.
Section 3.3 The measures used to stabilise the light output from commercially available
luciferase and luciferin.
Section 3.4 Stabilisation of luciferase preparations.
Section 3.5 Use of the biosensor to measure aqueous concentrations of solvent.
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3.1 Equipment for detecting light output
Two machines were available for detecting the light output from the luciferase reaction, 
the Perkin Elmer LS30 mulitmode spectrophotometer (Perkin Elmer, USA) and the Bio­
orbit 1253 luminometer. Since at this stage the light output from the luciferase reaction 
was a brief flash rather than a steady glow (Figure 3-1), the machines were compared as 
fluorimeters, with flourescein as the assayed compound.
3.1.1 Perkin Elmer LS30
The multi-mode LS30 spectrophotometer has a flow cell as the detection window through 
which a pump transports the test sample. Although this provides reproducible results for 
the detection of fluorescein, it was found that it took 15 s for the test fluid to be pumped 
from the reaction container to the measuring window. For this reason the LS30 could not 
be used to measure a fast reaction. The detection system could only be operated once the 
test volume had entered the detection window and the pump had stopped.
Furthermore the minimum reaction volume required was lOmL so that the cost of 
luciferin and luciferase would prohibit its use as a biosensor able to handle large numbers 
of samples. The LS30 was therefore ruled out as the useful detection system for luciferase 
and its development in measuring solvent concentrations.
3.1.2 Bio-Orbit 1253 luminometer
The Bio-Orbit 1253 is a photomultiplier tube (PMT) based luminometer. This design is 
more sensitive to light than spectrophotometry, so can detect lower light levels and 
samples of a lower concentration. The light tight measuring chamber is enclosed within a 
rotating tower that prevents exposure of the PMT to any external illumination. The sample 
(0.5 mL to 1.5 mL) is contained within a cuvette and so requires smaller amounts of test 
mixture than the LS30. Measurement of the light output is over a period of 1 s using 
manual control. The Bio-Orbit 1253 can also be connected to a PC for on line control. In 
this case using measurements over a period of 0.1 s are possible (LabVIEW®,
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Section 3.5). The Bio-Orbit 1253 was able to detect the flourescein and the low sample 
volume and fast response conferred a useful advantage when compared with the LS30.
For these reasons the Bio-Orbit 1235 was selected as the detection apparatus for all 
development work.
3.2 Stabilisation of light output from the Enzymatix ATP kit
3.2.1 The Enzymatix ATP kit reaction profile
An ATP detection system (Enzymatix, UK) was used to test the Bio-Orbit 1253 
luminometer assay for response tailing and linearity of response to ATP. The Bio-orbit 
luminometer was found to have a linear response up to 4000 units (Figure 3-2). The 
sensitivity to ATP can be decreased by a dilution of the luciferase-luciferin mixture. In 
this way, higher concentrations of ATP can be determined. However the brief flash of 
light from the reaction was not suitable for its use as a means of measuring aqueous 
concentrations of solvents, for which purpose a steady glow of light was considered more 
useful.
3.2.1.1 Effect of /i-hexanol on the Enzymatix ATP kit
The effect of hexanol on the kit was tested to see if  it would respond in the same way as 
reported with pure luciferase and luciferin (Franks & Lieb, 1984). Hexanol at a 
concentration of 60 mM was found to activate the reaction to a small degree but cause a 
rapid decrease in the signal stability. At concentrations above 70 mM, hexanol reduced 
the initial maxima and the stability of the signal (Figure 3-3).
The results confirm that alcohols function as inhibitors of the reaction at high 
concentrations as documented (Franks & Lieb, 1984), but at low concentrations, promote 
the reaction. This has not been reported. When hexanol was added to a concentration of 
250 mM the stability of the signal improved with a decay rate of less than 10 % measured 
per minute. However since the purpose of developing the luciferase assay is as a measure 
of solvent concentration it is not appropriate to use hexanol or any other solvent as a 
means of stabilising the light output. On the other hand the varying light output at low
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concentrations of hexanol, and in the control stresses the need for a stable light output if 
the system is to be used to measure solvent concentrations.
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Figure 3-2 Response of the Enzymatix ATP detection kit to increasing 
concentrations of ATP.
The kit at a 16-fold dilution was tested with various concentrations of ATP. 
The reaction was monitored by luminometry (Bio-Orbit 1253 luminometer). 
The initial dilutions of material and measurements were performed as directed 
by the manufacturer. Activity was measured in Relative Light Units (RLU) and 
is a function of the photomultiplier tube mechanics.
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Figure 3-3 The effect of hexanol on the profile of the Enzymatix ATP 
detection kit.
Kit was diluted to 1/16 and the reaction was initiated with the addition of ATP 
to a final concentration of 330 pM. The reaction was monitored by luminometry 
using a Bio-Orbit 1253 luminometer. Concentration of hexanol, ( •  ) control - 
no hexanol, ( ■  ) 60 mM, ( A ) 80 mM, ( ▼ ) 125 mM, ( ♦ ) 185 mM, ( +  )
245 mM, ( X  ) 490 mM.
3.2.2 Inhibition of the Enzymatix ATP kit with PPj
PPi is produced in the first reversible step of the reaction and so the use of PPj as an 
inhibitor was tested. PPi inhibited the reaction at all concentrations and improved the 
signal stability particularly at concentrations in the region of 0.5 -  1 mM. However the 
actual signal response is reduced almost 10-fold (Figure 3-4).
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While the inhibitor could be used to improve the accuracy of ATP detection by reducing 
the error in measuring the initial activity, PPi cannot be used to stabilise the solvent 
detection system since further inhibition will result with the addition of alcohols. Further 
inhibition of light output leads to an unstable signal from the luminometer and an initial 
activity, which is dependent on time. Inhibitors that act at the binding site were therefore 
abandoned for other methods of reducing the signal decay rate.
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Figure 3-4 The effect of inorganic phosphate on the luciferase reaction 
profile.
The reaction was monitored by luminometry (Bio-Orbit 1253 luminometer). 
Concentrations of PPi used: ( ■  ) control, ( •  ) 50 pM, ( A ) 100 pM, ( ▼ ) 
500 pM, ( ♦ ) 1 mM.
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3.3 Stabilisation of light output from commercially available 
luciferase and luciferin
The effect of the concentration of either luciferase or luciferin on the reaction profile could 
not be investigated using the ATP kits either from Enzymatix or from Sigma since both 
substrate and enzyme are premixed. Details of the components in the Sigma kit are shown 
in Table 3.1 and are typical. Data from this ATP kit are not shown, but they were similar 
to results obtained from the Enzymatix kit. To allow a better investigation of the assay, 
the components of the reaction were obtained from the supplier. The reaction was 
characterised starting from published data (Franks and Lieb, 1985).
Component Concentration
Luciferase (firefly) 0.04 mg/mL
Luciferin 0.26 mM
HAS 4 mg/mL
MgS04 19.5 mM
EDTA 1.95 mM
Glycine salts 0.195 M
Tris 0.325 mM
Table 3-1 Constituents of ATP detection system.
Product No. L0633 as supplied by the Sigma chemical Company and 
diluted to a final concentration of 20 mg of solids to mL of water.
3.3.1 Effect of luciferin ind luciferase concentration
If the luciferin (0.1 pM), and luciferase (50 pg/mL), were mixed for 5 mins before being 
diluted with gly-gly buffer and MgSC>4 the light output rose very slowly (Figure 3.6). A 
comparison, with Figures 3.4 and 3.5 shows that the maximum light intensity was very 
low.
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In contrast when high concentrations of luciferase (62.5 - 125 pg/mL) are added to 2.5 pM 
luciferin there is a flash of light, which decays rapidly. Only if the luciferase concentration 
is low (12.5 pg/mL) is the glow of light stable, although it is much reduced in intensity 
(Figure 3.6). However even at these low concentrations of luciferase there is an initial 
burst of light before the steady glow begins unless the luciferin concentration is also 
reduced to a very low level (0.125 pM) (Figure 3.7).
Although the latter conditions give a low light output it is easily measured in the Bio-Orbit 
luminometer and these conditions, (0.125 pM luciferin, 12.5 pg/mL luciferase), formed 
the basis of the standard assay (Figure 3.7).
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Figure 3-5 The effect of premixing luciferase and luciferin on the kinetics of 
the reaction.
The reaction was monitored by luminometry (Bio-Orbit 1253 luminometer). 
Luciferin (0.1 pM), and luciferase (50 pg/mL), were mixed for 5 mins before 
ATP and other reagents were added.
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Figure 3-6 The effect of the luciferase concentration on the reaction profile. 
Luciferase (100 pL) up to a concentration of 1 mg/mL added to 800 pL of 
reaction mixture containing 25 mM gly-gly, 8.75 mM MgS(>4 , 2.5 pM 
luciferin, and 625 pM ATP. Plot of activity vs. [luciferase] is a straight 
line. Concentration of luciferase, ( ■  ) 125 pg/mL,( •  ) 62.5 pg/mL,
( ▲ ) 25 pg/mL ( ▼ )12.5 pg/mL
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Figure 3-7 The effect of luciferin concentrations on the reaction profile.
Luciferin was added to a concentration of 2.5 pM added to 800 pL of reaction 
mixture containing gly-gly 25 mM, MgSC>4 8.75 mM, luciferase 1.25 pg/mL, 
and ATP 625 pM. The reaction was monitored by luminometry (Bio-Orbit 
1253 luminometer).
Concentration of luciferin in the assay: ( ■  ) 2.5 pM, ( •  ) 1.25 pM, ( A )
0.125 pM.
3.3.2 Effect of ATP concentrations
The concentration of ATP in the final assay mixture was decreased and the effect of the 
lower concentration of ATP on the signal peak and the profile of the reaction was 
determined.
It was found that when lower concentrations of ATP were used the maximum activity 
decreased in a similar way to the Enxymatix ATP detection system used earlier (Figure 3-
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4). However at the low luciferin and luciferase concentrations (0.125 pM and 12.5 pg/mL 
final concentrations), the concentration of ATP had little effect on the rate of signal decay 
so that the decay rate was within 10 % per minute (Figure 3-8). This effect can be more 
clearly seen when the initial activity is scaled to an initial activity of 100 % (Figure 3-10). 
An intermediate concentration of ATP (625 pM) was chosen for subsequent experiments.
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Figure 3-8 The Effect of ATP concentration of light output.
Initial output at 1.25mM ATP taken as 100%.
Data used is as for Figure 3-7 with 0.125 pM and 12.5 pg luciferase The 
graph shows the effect of ATP concentration on the rate of signal decay. 
Concentration of ATP, ( ■  ) 1.25 mM, ( •  ) 630 pM, ( ▲ ) 500 pM, ( ▼ ) 
250 pM, ( ♦ ) 50 pM.
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Figure 3-9 The effect of the ATP concentration on the signal stability. 
Concentration of ATP, ( ■  ) 1.25 mM, ( •  ) 630 pM, ( A ) 500 |iM ( ▼ ) 250|iM, 
( ♦ ) 50jiM.
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3.4 Improving the stability of Firefly Luciferase by Medium 
Engineering
3.4.1 Introduction
The low stability of luciferase in aqueous solvents can lead to errors in the determination 
of ATP concentrations and in the measurement o f concentration of solvents in the aqueous 
phase. The stability was enhanced by varying the buffer type, ionic strength and with 
additives including sorbitol (D-glucitol) and glucose.
Both luciferin and luciferase are unstable at room temperature and prone to damage when 
freeze-dried. The activity of luciferase can decrease during the assay period. Therefore 
the controls must be repeated frequently and quickly. Luciferin is readily oxidised to 
oxyluciferin. The action of an aqueous phase accelerates the oxidation so that luciferin is 
most stable in the dry form.
Freeze-drying, the use of sugars, modification of buffers and the concentration of enzyme 
will be tested to obtain a useful, highly stable enzyme preparation.
Luciferase and luciferin are required in a stable form in small aliquots that can be 
dissolved into gly-gly to give a working solution that can be used for a number of solvent 
assays.
3.4.2 The effect of the buffer concentration on the activity of luciferase
A range of gly-gly buffer solutions (12.5 mM to 2 M), were prepared at pH 7.8. Luciferase 
was added to a final concentration of 1 mg/mL. The activity of luciferase was measured at 
the different buffer concentrations.
At high buffer concentrations the activity decreased and above 100 mM the activity 
recorded was lower than the control (12.5 mM) suggesting that the reaction is inhibited at 
high ionic strength solutions (Figure 3-10). When the buffer concentration decreased the 
activity increased. A maximum rate of activity was noted at 30 mM, below this 
concentration the activity decreased and at 1.2 mM the activity was only 20 % of the 
maximum activity.
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3.4.3 The effect of the buffer concentration on the stability of luciferase
The stability of luciferase was measured in 25 mM gly-gly and 1 M gly-gly. The solutions 
were stored at 4 °C and the activity recorded over a period of 2 hr. The 1 M solution was 
diluted to 25 mM and the activity measurements adjusted for the concentration of 
luciferase.
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Figure 3-10 The activity of luciferase in high concentrations of gly-gly 
buffer, pH 7.8.
The final luciferase concentration was 1.25 mg/mL
It was found that the activity of luciferase decreased in both samples over time. The rate 
of activity loss in the 1 M buffer was lower than for the 25 mM buffer (Figure 3-11).
High buffer concentration may act to increase the conformational stability of luciferase. 
The luciferase enzyme is a dimer of two non-identical subunits. The ionic interactions of
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the two subunits could be sensitive to the ionic strength of the media and this could be 
important in ensuring that luciferase exists as the dimer.
3.4.4 The effect of luciferase concentration on its stability
Luciferase solutions 1 mg/mL and 0.1 mg/mL in 25 mM gly-gly were stored at 4 °C and - 
20 °C. After one week, the activity of the solutions was tested.
At all concentrations and temperatures the activity is reduced (Figure 3-12). The loss of 
activity was minimised when the concentration of luciferase was high and the storage 
temperature was low.
3.4.5 The effect of BSA on stability of luciferase
1 mg/mL luciferase, in 1 M gly-gly, was prepared. BSA was added to the solution at 
concentrations of up to 8 mg/mL. The activity of the luciferase in BSA preparation was 
assayed after incubation at 4 °C for 35 min.
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Figure 3-11 Effect of buffer concentration on the stability of 0.1 mg/mL 
luciferase stored of various times at 4°C in gly-gly buffer. In all cases the 
concentration of gly-gly is reduced to 25 mM for activity assays (concentration 
of gly-gly buffer during storage phase: ( •  ) 1 M, ( ■  ) 25 mM.
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Figure 3-12 Effect of storing high concentrations of luciferase at -20 °C and +4 °C. 
Storage conditions (concentration of luciferase and temperature): ( ■  ) 1.0 mg/mL 
Control, ( •  ) 1.0 mg/mL -20 °C, ( A ) 0.1 mg/mL -20 °C, ( T  ) 0.1 mg/mL, 4 °C.
The control sample was prepared just before the assay was performed.
It was found that concentrations of BSA lower than 3 mg/mL increased the initial activity. 
At concentrations of BSA higher than 3 mg/mL a 20 % loss of activity was recorded 
(Figure 3-13).
At all concentrations of BSA, the loss in activity at 4 °C was reduced compared to controls 
without BSA. The action of BSA was thought to be non-specific reducing the contact at 
the surface of the plastic Eppendorf tubes or at the air/liquid interface where unfolding 
could occur. BSA however, was not used in the final preparation because of the 
requirement to remove extraneous sources of protein from the system that might prove to 
be complicating factors when the action of solvents on luciferase is tested.
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Figure 3-13 The effect of BSA on the stability of luciferase. BSA was added 
to a solution of luciferase in 25 mM gly-gly buffer to give the final 
concentrations indicated (up to 10 mg/mL). The enzyme solution was stored at 
4°C for 5 or 35 min before assay. 10 pL of the enzyme solution was added to 
the normal reaction mixture. Storage times, (■  ) 5 min, ( •  ) 35 min.
3.4.6 Effect of sorbitol in high molar strength gly-gly buffer
The use of sugars and polyhydric alcohols has been documented as an effective method of 
increasing the thermal stability of enzymes (Devi & Rao, 1998). The effect of sorbitol on 
the stability of a solution of luciferase in gly-gly buffer was tested.
With gentle heating at 40 °C, sorbitol was dissolved in 1 M gly-gly pH 7.8, to a final 
sorbitol concentration of 1 g/mL. At concentrations above 2 g/mL the solution was found
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to behave as a glass at -20 °C, with very low flow characteristics (Table 3-2). Luciferase 
was soluble in sorbitol at 1 g/mL, 2 M gly-gly, to at least 1 mg/mL.
[sorbitol]
(g/mL)
[sorbitol]
(M)
State at -20°C
0 0 Solid (ice)
0.25 1.40 Solid (ice)
0.50 2.80 Solid (ice)
0.75 4.10 Liquid
1.00 5.49 liquid
2.00 11.00 glass/liquid
3.75 20.59 glass
Table 3-2 States of sorbitol solutions in 2 M gly-gly, at -20 °C.
The solubility of luciferase was aided by the addition of the enzyme to sorbitol 
gly-gly at 30 °C.
Luciferase was dissolved in 1 g/mL sorbitol, 2 M gly-gly, to a concentration of 1 mg/mL. 
The effect of sorbitol on the activity luciferase reaction was then assayed.
The addition of 10 mM sorbitol, to the luciferase reaction mixture has no effect on the rate 
of reaction. Higher concentrations tend to reduce the activity. A 1.4 M sorbitol decreased 
the activity of the luciferase reaction to only 3 % when stored at 4 °C for 2 hours 
(Figure 3-14).
3.4.7 Sorbitol as a protective agent in lyophilisation
As small aliquots of luciferase are required for the routine assay, the use of lyophilisation 
can be used to dehydrate small amounts of diluted luciferase. Up to 70 % of the activity 
can be lost in each freeze thaw cycle of unprotected luciferase. Sorbitol is an effective 
protector of enzyme conformation. Sorbitol may be used to increase the thermal stability 
of luciferase. This allows the enzyme to be stored at higher temperatures, such as room 
temperature.
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Luciferase 1 mg, and sorbitol lg were dissolved into 2 M gly-gly (1 mL) buffer pH 7.8. 
100 pL aliquots of the luciferase solution were then added to 1 mL Eppendorf tubes. The 
solutions were then cooled to -20 °C and lyophilised (Speedvac SC 100, Savant, USA) for 
24 hr at a low dry rate. A solution of luciferase in gly-gly buffer was also lyophilised in 
the absence of sorbitol.
The freeze-dried powders were then reconstituted with water to a 1 mg/mL luciferase 
concentration and incubated at 20 °C. The activity of the reconstituted luciferase sorbitol 
mixture was then tested and compared with reconstituted enzyme without sorbitol and 
enzyme sorbitol mixture that had been stored at -20 °C for 24 hr.
The luciferase sorbitol mixture that had been stored at -20 °C for 24 hr. lost 40 % activity 
when compared to the reference. The luciferase sorbitol mixture that had been lyophilised 
lost 5 % activity
3.4.8 Discussion
High buffer concentrations were required for the retention of enzyme activity during 
storage. High concentrations of buffer were found to decrease the activity of the 
bioluminescence. Luciferase is a dimer held together by ionic interaction.
Luciferase may have been stabilised by the dissolution in high ionic strength 2 M gly-gly, 
buffer, pH 7.4. The addition of sorbitol to the reaction mixture limited the activity at high 
concentration but conferred an advantage to storage. At low concentrations such as in the 
diluted reaction mixture there was only a small effect on the activity. These two effects 
can be utilised in the formulation of luciferase to yield a stable enzyme that retains high 
stability in the diluted assay mixture.
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Figure 3-14 The effect of sorbitol on the stability of luciferase at 4 °C for 
2  hours.
Assay conditions: 1.0 mg/mL Luciferase in 2 M gly-gly buffer pH 7.4, with 
increasing concentration of sorbitol. The activity was measured at the start of 
the reaction ( ■  ), and after 2  hr ( •  ).
Luciferase contains two identical subunits, and it is likely that the high concentrations of 
gly-gly buffer and of the sorbitol influence their interaction. This could be tested with gel 
electrophoresis or gel chromatography. Whatever the cause both reagents do have a 
marked effect on the stability of solutions of luciferase. At 4°C 0.8 M sorbitol protects 
the luciferase for at least two hours (Figure 3-14), but some activity is lost at -20°C even 
at sorbitol concentrations high enough to prevent freezing (Table 3-2). On the other hand 
the solid obtained after freeze-drying from sorbitol solutions appears to be more stable. 
We have found the latter method useful in preparing the small quantities of luciferase
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required for occasional ATP assays. A sample of luciferase, which is normally only 
stable in the dry state at -20°C appears to retain most of its activity over 24 hr at 22°C 
when sorbitol is present. Clearly high concentrations of both the gly-gly buffer and of the 
sorbitol are useful in preparing stable solutions of luciferase, and they should find some 
practical use in assays for ATP.
The effect of albumin (BSA) is more difficult to understand. This protein is known to bind 
small molecules, and it is possible that it interacts directly with luciferin itself as well as 
with the luciferase. It has been shown to stabilise the luciferase isolated from Luciola 
mingrelica. This may account for its dual action, of increasing the light intensity at low 
concentrations where it stabilises the enzyme, and of inhibiting the intensity at higher 
concentrations where it binds the substrate. This latter effect suggests that any protein, 
which binds luciferin, could affect assays for ATP.
3.5 Determination of solvent concentration using the biosensor
The use of the biosensor to determine the concentration of H-alkanes and w-alcohols in 
aqueous solution and in mixtures of membranes is discussed here. Also the use of a 
program for online control, data capture and data handling is described. The effect of 
online versus manual control on the accuracy of the data is also described.
Various anaesthetics can inhibit the conversion of luciferin to oxyluciferin by luciferase 
from the North American firefly. Media engineering has been used to successfully 
stabilise luciferase at 4 °C and modify the reaction profile from flash to steady state 
kinetics. The luciferase - luciferin reaction will be challenged by a series of w-alcohols 
from methanol to pentadecanol. The inhibition of the luciferase - luciferin reaction 
increases with the hydrophobicity, and the chain length of the solvent, (Franks & Lieb, 
1986). The concentration required to inhibit the reaction by 50 % (IC50) will be recorded 
for each ^-alcohol and w-alkane. In this way the reaction will be used as a biosensor for 
solvents in membrane/buffer mixtures.
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3.5.1 Methods
Luciferase was taken from storage (Section 3.2) and revived with RO water (1 mL) to a 
1 mg/mL luciferase concentration in 1 g/mL sorbitol, 1 M gly-gly, pH 7.8. 10 pM luciferin, 
70 mM MgSC>4 and 10 mM ATP was also obtained.
Water (820 pL) was added to the 1.5 mL reaction vessel and then in strict order, luciferase 
(10 pL), luciferin (10 pL), and MgSC>4 (10 pL). The base line luminescence reading was 
then taken and ATP (50 pL) injected into the vessel. Changing the order of addition can 
have a dramatic effect on the reaction profile. For example adding luciferase to luciferin 
can cause a temporary inactivation of the enzyme. Readings were then taken every 
second.
For very hydrophobic solvents the IC50 point was very close to the solubility limit. It was 
for this reason the assay volume was increased from 800 pL (Section 3.1) to 900 pL.
For recording IC50 data, the assay was repeated, replacing a volume of water with the same 
volume of solvent. The volume of solvent added was varied such that a wide range of 
final solvent concentrations could be assayed. Luminescence data was recorded manually.
3.5.2 Manual data capture experiments
Luminescence data was taken manually by pressing the ‘start’ key at regular intervals. The 
values that appeared in the display window were recorded. However large errors were 
encountered when capturing the data manually, but the time of first measurement was 
reached from 3 sec (using manual operation) to -0.1 sec (using on-line control).
3.5.3 Automated data capture experiments
A Graphical programming utility (LabVIEW®) was used to automate the control of the 
Bio-Orbit luminometer. This was required for fast control and data capture. A simple 6 
frame sequence was used for the basis of the control package with data stored as a text 
(*.txt) file to be used by other graphical display applications (Microsoft Excel, Origin).
3.5.4 Results
Methanol was found to inhibit the reaction. Log IC50 value for the inhibition was 0.34 ± 
0.02 M inhibits the reaction (Figure 3-15) also provides a ‘standard curve’ from which to
83
estimate the concentration of methanol in other aqueous samples. It is only necessary to 
measure the degree to which the unknown solution inhibits the luciferase for the 
concentration to be directly estimated from the figure. A series of ‘standard curves’ is 
easily constructed for the range of solvents under study. The advantage of the method is 
that only the aqueous concentration of the solvent affects the luciferase reaction; solvent, 
which is distributed in other phases of a complex mixture has no effect.
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Figure 3-15 The effect of methanol on the biosensor.
Percentage of the initial activity remaining ( •  ) on addition of alcohol is 
shown.
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Methanol 2 M 0.30 octanol 510 pM -3.29
Ethanol 360 mM -0.44 nonanol 172 pM -3.76
Propanol 330 mM -0.48 decanol 44 pM -4.36
Butanol 150 mM -0.82 undecanol 7.7 pM -5.11
Pentanol 29.4 mM -1.53 dodecanol 2.81 pM -5.55
Hexanol 11.9 mM -1.92 tridecanol 0.25 pM -6.60
Heptanol 1.77 mM -2.75 tetradecanol 0.26 pM -6.58
Table 3-3 The effect for alcohols in the series methanol to tetradecanol using 
Lab VIEW®, (National Instruments™Texas, USA) to capture data.
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Figure 3-16 The IC50 of w-alcohols from methanol to tetradecanol on the 
luciferase in engineered media.
The data ( •  ), was recorded using manual capture.
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/z-alkane IC50 Log (IC5o) /z-alkanes IC50 Log (IC5o)
pentane 125 pM -3.9 decane 200 nM -6.7
hexane 79 pM -4.1 undecane 63 nM -7.2
heptane 79 pM -4.1 dodecane 16 nM -7.8
octane 50 pM -4.3 tridecane 12.6 nM -7.9
nonane 3.1 pM -5.5
Table 3-4 Effect of w-alkanes on the luciferase reaction (automated data 
capture).
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Figure 3-17 Effect of «-alkanes on the luciferase reaction (automated data 
capture)
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The experiment was repeated several times for all alcohols from methanol to tetradecanol 
and the values of IC50 for each alcohol were calculated (Table 3-3). 
n-alcohol's inhibited the luciferase reaction. The concentration of alcohol required to 
reduce the activity by 50% decreased with increasing chain length. Tetradecanol however, 
did not follow the trend. The concentration required to inhibit the enzyme by 50 % does 
not decrease and was similar to tridecanol. The n-alcohols with a carbon chain length 
greater than 14 could not reach the IC50 point because the solubility was lower than 
required.
The IC50 data for both primary alcohols (Table 3-3), and alkanes (Table 3-4), were lower 
than previously reported (Franks & Lieb, 1985) using manual data capture. Higher 
concentrations of solvent were required to give the same inhibition. This result can be 
explained by the fast kinetics of the reaction. Using manual control the first accurate 
reading that can be recorded is at 3 s after initiation of the reaction using a manual 
injection of ATP. If the initial activity is measured at 3 s then the measured activity is 
lower than the actual initial activity. The concentration required to reduce this activity will 
be lower than to reduce the actual activity by 50% (IC50) The more accurate the reading of 
the initial activity the more accurate the IC50 data. Fast on-line data capture is required for 
accurate determination of inhibition data.
When the latter IC50 values for a range of alcohols and alkanes were plotted (Figure 3-16 
and 3-17), the data was similar to the historical values (Franks and Lieb, 1984).
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4. Isolation of P450BM3 from Bacillus
megaterium
The attempted expression of P450 BM3 from B. megaterium is documented in this section.
4.1 Abstract
B. megaterium ATCC 14581 was grown on complex and casamino acid salts media (Black 
et a l 1994) to a scale of 2 L. Pentabarbital was added to the growing culture at mid-log to 
induce the production of Cytochrome P450 BM3. High cell densities of B. megaterium 
were obtained from cultures on complex media, but very low cell densities were observed 
when using casamino acid salts media. Several sources of casein were tested but neither 
spectrophotometry or light microscopy could obtain measurable biomass. Cells from 
complex media were harvested, ruptured by homogenisation and an attempt was made to 
purify P450 BM3 by affinity chromatography. P450 BM3 was not detected using 
spectrophotometric or catalytic techniques.
4.2 Introduction
The only well-characterised bacterial cytochrome P450 that belongs to class II is 
cytochrome P450 BM3 from B. megaterium. This soluble enzyme is unusual as it contains 
both a flavoprotein reductase and a P450 component in a single polypeptide chain of 1048 
residues (Narhi & Fulco 1987). P450 BM3 is therefore catalytically self-sufficient in the 
mono-oxygenation of fatty acids requiring only NADPH and 0 2 to function in the 
hydroxylation of long chain fatty acids. P450 BM3 is also unusual in that it is the only 
prokaryotic P450 known to resemble the mammalian microsomal P450 microoxygenases 
(Black et a l , 1994). After limited proteolysis with trypsin in the presence of substrate, the 
holoenzyme [molecular weight (RMM) 119kDa], is cleaved into (i) the NH2 terminal 
(Heme) domain (RMM 55kDa), and (ii) the C 02H terminal (flavin) reductase domain 
(RMM 66kDa), which contains FAD and FMN (Li et al,, 1991). Therefore, P450 BM3 
resembles microsomal P450s, which requires FAD/FMN containing reductase for activity.
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The heme (NH2) domain incorporates a heme group and is capable of binding substrates 
and 0 2, whereas the flavin (C02H) domain accepts electrons to the heme active site in an 
intramolecular electron transfer reaction. After trypsin digestion, the heme domain retains 
the ability to bind substrates and react with CO to give a characteristic peak at 450 nm. 
The flavin domain retains the NADPH dependent cytochrome c reductase activity, which 
can be used to monitor P450 activity. The monooxygenase activity Although the reported 
activity of the reconstituted system by different authors varies: (Munro et al., 1994), 
reports an activity of only 0.3% measured by NADPH fatty acid consumption, whereas 
(Boddupalli et al., 1992), reports an activity of 80% when measured by oxygen 
consumption.
Production of P450 BM3 (an inducible enzyme) from B. megaterium was investigated 
using various casamino-acid salts and complex media.
4.3 Materials
4.3.1 Source of B. megaterium
B. megaterium (ATCC 14581), was supplied by the American Type Culture Collection.
4.3.2 Solid media
Casamino acid salts media based on previous work (Black et al., 1994), and a complex 
liquid media (Nutrient broth, Oxoid) was produced.
4.3.2.1 Casamino acid salts solid media
Three components (Table 3-1) of x2 concentration were autoclaved separately and then 
combined in the ratio of 98:1:1. The x2 salts media was then added in equal volume to 
24 g/L agar technical (Oxoid) to give a final concentration of 12 g/L. Solid media was left 
to cool and later incubated at 30 °C for 5 days. Contaminated plates were discarded.
4.3.2.2 Complex solid media
Nutrient Agar plates were made to the manufactures specifications of 28 g/L agar (Oxoid 
Ltd.) in RO water. The solution was then autoclaved (120°C, 20 min) and 30 mL poured
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into each petri dishes. Solid media was left to cool, then incubated at 30 °C for 5 days. 
Contaminated plates were discarded.
4.3.3 Liquid media
Casamino acid liquid media (Black et al., 1994), and a complex liquid media (Nutrient 
broth, Oxoid) were produced.
4.3.3.1 Casamino acid salts liquid media
Three components (Table 4-1) were autoclaved separately and then combined in the ratio 
of 98:1:1.
Part Reagent Molecular formula Cone
1 Potassium nitrate k n o 3 100 mM
Potassium sulfate k 2so 4 1.0 mM
Monobasic potassium phosphate KH2P0 4 50 mM
Magnesium sulfate heptahydrate MgS04 7H20 0.5 mM
Manganous sulfate tetrahydrate MnS04 H20 10 pM
Ferric sulfate heptahydrate Fe2(S04)3 7H20 33 pM
zinc sulfate heptahydrate ZnS04 7H20 50 pM
casein hydroxylate various types (Table 4-2) 5 g/L
citric acid monohydrate C4H80  7H20 4.17 mM
Sodium hydroxide NaOH 5 g/L
2 D-glucose C6H12O6 2.78 M
calcium chloride dihydrate CaCl2 2H20 56.45 mM
3 ferric ammonium citrate 4 g/L
Table 4-1 Casamino acid salts liquid media composition.
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Name Supplier Source Total
nitrogen
(%)
Total
NaCl
(%)
Total amino 
Nitrogen 
(%)
Method
Of
Production
Casamino
acids
Technical
Difco Bovine
milk
7-10 25-35 n.a acid
hydrolysis
Hy-Case SF Sigma Bovine
milk
13.8 0.4 n.a acid
hydrolysis
Hy-Case
Amino
Sigma Bovine
milk
8.2 34.3 n.a. acid
hydrolysis
N-Z-Case
Plus
Sigma Bovine
milk
13.3 n.a 6.6
Table 4-2 Details of the casein hydroxylate types used.
4.3.3.2 Complex liquid media
Nutrient brothl3 g/L. Components in a typical batch can be seen (Table 4-3).
Component % (w/w)
'Lab Lemco' Powder 7.70
Yeast extract 15.4
Peptone 38.5
Sodium Chloride 38.5
Table 4-3 Composition of the components in nutrient broth, %(w/w).
4.3.4 Downstream processing buffers
Cells of B. megaterium were homogenised in wash buffer I (0.1 M potassium phosphate, 
0.1 mM dithiotreitol, 1 pg/mL leupeptin, 1 pg/mL pepstatin A, 1 mM EDTA, pH 7.4).
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Wash buffer I contained components to reduce disulfides and prevent proteolytic 
degradation during cell breakage and purification.
Wash buffer II (0.5 M potassium phosphate, 0.1 mM dithiotreitol, 1 mM EDTA, pH 7.4) 
was used to increase the ionic strength of the environment of the affinity matrix to 
encourage the elution of components not bound to the matrix
Wash buffer III (0.5 M potassium phosphate, 0.1 mM dithiotreitol, 1 mM EDTA, 3 mM 2’- 
AMP, pH 7.4) wash used to remove specifically bound oxidoreductases added to the 
matrix.
P450 BM3 was eluted with the addition of elution buffer (potassium phosphate 0.5 M, 
dithiotreitol 0.1 mM, EDTA 1 mM, 2-AMP 50 mM, pH 7.4) with a high concentration of 
the competitor AMP.
4.3.5 Spectrophotometry
UV spectrophotometric assays and absorbance readings were recorded (ATI Unicam UV2 
UV/Vis photospectrometer). A water bath and immersion thermostat (VFK, Grant) 
provided temperature regulation.
4.3.6 Light microscopy
A light microscope (Olympus CH) was used for all microscopy work. Growing 
microorganisms were viewed (D Plan 100 oil optic) with an overall magnification of 
lOOOx. Cedar wood oil was used to lubricate the lens and the cover plate.
4.3.7 Fermentation equipment and analysis
Fermentation was performed in a glass bioreactor (2.1 L Inceltech LH series 210). 
Analysis of fermentation exit gases was achieved using 0 2 and C 02 (Ingold) detectors.
This information was passed on to data logging personal computers where values of the 
carbon dioxide evolution rate (CER), oxygen uptake rate (OUR) and the respiratory 
quotient (RQ) are calculated. Data logging for the gas analysis and pH was achieved using 
a Real Time - data acquisition system (RT-das). These logged information from individual 
sender units at 3min intervals. Temperature, agitator speed and pH data were also 
recorded using this system.
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4.4 Methods
4.4.1 Maintenance of B. megaterium
13 g/L nutrient broth (3 mL) was added aseptically to the vial, mixed and transferred to a 
test tube with nutrient broth (5 mL). After 3 days of incubation at 25 °C growth was 
detected and a sample streaked on to nutrient agar plates. When heavy growth was seen 
individual colonies were inspected by light microscopy and then used to inoculate of 
nutrient broth (5 mL). Populations from this test tube were then stored at -20 °C in 20 % 
(v/v) glycerol. Frozen stock cultures were revived at 25 °C in nutrient broth and plated on 
to solid nutrient agar.
4.4.2 Spectrophotometric absorbance measurements
The biological mass (biomass) of the culture was determined by absorbance measurements 
at 670 nm (A670) (Figure 4-2). When the absorbance of the culture exceeded 0.7 the 
sample was diluted to within the range 0.3 to 0.7 absorbance units for accuracy.
4.4.3 Solid media growth
Samples of B. megaterium were removed from -20 °C and revived in liquid nutrient broth 
(5 mL) until germination was detected by A670 measurements and light microscopy 
(typically 16 hr). Cultures were transferred to solid media and incubated at 30 °C. After 
2-3 days heavy growth was seen, plates were stored at 4 °C for 6 weeks.
4.4.4 Shake flask fermentation
Starter cultures were prepared by either inoculating nutrient broth or casamino acid salts 
medium (100 mL) in a 500 mL baffled shake flask with a single colony from a nutrient 
agar plate. Incubation was carried out for 16 hr on an orbital shaker (200 RPM, 37 °C).
4.4.5 2 L Fermentation
Part 1: (1.96 L) of the casamino acid salts medium was sterilised in situ by heating with 
steam to 121 °C at 1.1 bar pressure for 20 min. At this stage the medium was allowed to
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cool to 37 °C. Parts 2: (20 mL) and 3: (20 mL) was then added and the temperature 
maintained at this level. The inoculum (100 mL), from a 500 mL shake flask, was 
transferred to the 2 L vessel to give a final volume of 2.2 L and growth was allowed to 
proceed. Temperature was controlled at 37 °C while the pH was not controlled. Agitation 
rate was set at 800 RPM to give good dispersion of air into the vessel at a rate of 5 L/min. 
Growth was followed and harvest occurred when the DOT began to rise after induction,
4.4.6 Induction of P450 BM3
B. megaterium contains the cytochrome P450 BM3 and is inducible by barbiturate drugs 
(Shaw & Fulco, 1983). It has been demonstrated that a transcriptional repressor, termed 
BM3R1, is directly involved in mediating this response (Shaw & Fulco, 1993). BM3R1 
binds to an operator upstream of the P450BM3 operon and prevents transcription. 
Barbiturate drugs (Shaw & Fulco, 1993) and peroxisome proliforators (English et al., 
1994) interact with the BM3R1 and dissociate it from its operator allowing transcription to 
occur.
A aqueous solution of 0.5 g/L Sodium pentabarbital (Figure 4-1) in was added to the 
fermentation to achieve a final concentration of 5 mM at mid- log phase, shown by rapid 
increase of A67o values with time (Black, 1994).
ONa
Figure 4-1 Representation of sodium Pentabarbital
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4.4.7 Cell Harvest
Cells were harvested at early stationary phase shown by an increase in DOT following (up 
to 3 hr) induction. Harvested cells were concentrated to a cell paste by centrifugation 
(10,000 g, 20 min., 4 °C). The supernatant was poured away and the compacted cells 
suspended in wash buffer I, and centrifuged again.
4.4.8 Cell rupture by homogenisation
Clean cell pellet was suspended in the minimum amount of wash buffer I to a volume of 
40 mL. Cells were disrupted by homogenisation (micron Lab40, APV), releasing 
intracellular components. Adequate disruption of cells was provided by one pass at 4 °C, 
9,000 p.s.i.
4.4.9 Cell free extract
The samples of the cell homogenate were centrifuged (40,000g, 30 min. 4 °C). The 
supernatant fraction was poured into a chilled vessel and frozen at -70 °C until use.
4.4.10 Affinity Chromatography
Thawed cell free extract was then centrifuged (40,000 g  30 min., 4 °C) to remove any 
precipitate. Five column volumes of extract were loaded on to 2',5’-ADP agarose matrix, 
and then flushed with Reconstitution, wash and elution buffer (Table 4-4).
Buffer Column Volumes
Cell free extract 5
Reconstitution 10
Wash I 6
Wash II 5
Elution 7
Table 4-4 Elution protocol for P450 BM3
95
4.4.11 Assays
4.4.11.1 Reduction of cytochrome P450 BM3 with dithionite
Samples of wash buffers and elution buffers that had been passed through the column were 
assayed for the presence of cytochrome P450 by observing the reduced dithionite spectra. 
To 1 mL of sample, a small quantity (-20 mg) of solid sodium dithionite was added and 
CO was bubbled through for 1 min. the absorbance at 450 nm (A450) was taken against a 
reference of wash buffer.
4.4.11.2 Catalytic assay for P450 BM3
Substrate-dependent NADPH oxidation activity was assayed in the presence of sodium 
laurate. To a sample of P450 BM3 (1 mL), sodium laurate (500 pL) was added. The 
reaction was initiated by the addition of NADPH and the reaction followed by observing 
the decrease in A340 measurements
4.5 Results
4.5.1 Growth of B, megaterium on complex and casamino acids
Growth on complex media was vigorous giving dense cultures after only 24 hr. Wet 
weight (wwt) and dry weight (dwt) analysis showed that 13 g/L of nutrient yields a 
biomass of 8 to 9 g/L (wwt) and a wwt/dwt of -23 %. When B. megaterium colonies from 
complex solid media were transferred to casamino acid salts liquid media no growth was 
detected after an incubation period of 7 days. Cells of B. megaterium experienced an 
environmental shock when the change in nutrient base occurred and did not grow because 
of the partial shut down of these pathways. To over come this a growth stage on casamino 
acid salts solid media was incorporated. Samples of B. megaterium cultured on plates of 
complex media were sub-cultured onto fresh of casamino acid solid media in an attempt to 
switch on the pathways that were thought to be redundant in the colonies derived from 
complex media. To supply this nutrient several sources and varieties of casein were tested 
(Table 4-2). The biomass yields from the sources of casamino acid were undetectable and
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no improvement was seen. In order to obtain suitable quantities of biomass for the 
induction and purification of P450 BM3 the use of semi-defined media was abandoned.
4.5.2 Induction of P450 material
The effect of pentabarbital on the biomass of B. megaterium was determined for the 
addition of inducer at a time corresponding to the mid-log growth phase. Pentabarbital 
was added at mid-log because the cells are in their most active growth phase and most able 
to adapt to the addition of a carcinogen. Growth ceased with the addition of 6 mM 
pentabarbital. Lower concentrations resulted in higher biomass production. A 
concentration of 5 mM was found to reduce the growth but does not induce cell death (by 
light microscopy) therefore this concentration was used in the induction phase.
4.5.3 Spectrophotometric assay of wash buffers and elution buffers
Cells from a large-scale fermentation (2 L) were induced for the production of cytochrome 
P450 by the addition of pentabarbital at mid log growth phase. By the analysis of A280 and 
A260 spectral data, protein and DNA were present in the homogenate and in the samples 
from both wash and elution buffers. However an attempt to record A450 spectral data 
(reduced dithionite spectra) showed that there was no cytochrome P450 enzyme present. 
Cell free extract in fractions from wash buffers were tested for the presence of a A450 
absorbance maximum after the addition of sodium dithionite and bubbling CO for 1 min to 
indicate the presence of P450 material.
4.6 Conclusions
On the basis of the spectral data, no cytochrome P450 was present in the samples tested. 
This contrasts with the findings (Black et a l, 1994) who showed that the catalytic 
quantities were present using the above method. Catalytic assays for the activity of 
P450 BM3 confirmed the results of the spectral data.
Since the developments made, yielded no induction of P450 BM3 in the complex media it 
is concluded that the presence of P450 BM3 is transitory, expressed in low quantities, or 
not induced using this method.
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The lack of P450 BM3 may possibly be because of the different feeding strategies 
followed in this section and to that documented (Black et al., 1994). Media, rich in 
nutrients may have resulted in colonies susceptible to changes in the environment, such as 
the change to a week media or the presence of toxins, pentabarbital. The use of 
B. megaterium to produce the soluble form of P450 was abandoned. At this stage, the 
three component soluble P450cam from Pseudomonas putida or a high expression source 
of P450 BM3 was investigated.
4.6.1 Search of a high expression source of P450 BM3
P450 BM3 is a single polypeptide chain of amino acids. The cloning of P450 BM3 into a 
suitable host was found to be achieved (Miles et al., 1992). In the next section the 
production of E. coli and purified P450 BM3 is investigated. This route was chosen over 
the P450cam because of the apparent ease of growth induction and isolation (Black et aL, 
1994).
It was thought that some biosynthetic pathways in the colonies o f  B. megaterium cells 
grown on complex media were not induced. These pathways were thought to be essential 
for the growth on the semi-defined casamino acids salts media.
No improvement in the growth characteristics was seen and so the casamino acid source 
was thought to be deficient in a key amino acid (auxotropic) nutrient.
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0.0 0.5 1.0 1.5 2.0
A660. Sample undiluted
Figure 4-2 The absorbance of B. megaterium at 670 nm.
Absorbance measurements made for diluted and undiluted sample. Graph 
shows that at absorbance values above 0.8 the function becomes increasingly 
non-linear and that values above this value diverge from the actual value.
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5. Isolation of P450 BM3 from E. coli
5.1 Introduction
Native B. megaterium has been found to be a poor source of P450 BM3 (Section 4). The 
gene CYP102 encoding cytochrome P450 BM3 has been cloned in E. coli (Miles et aL, 
1992). P450 BM3 has been over expressed and purified to homogeneity (Miles et a l, 
1992). In this section colonies of P450 BM3 were obtained and quantities of high purity 
for solvent inhibition studies were made (Dellar & Turner, 19971). The purification was 
based on a modified method (Munro et aL, 1994).
5.2 Abstract
B. megaterium ATCC 14581 was grown on LB broth with ampicillin (Black et al., 1994) 
to a scale of 100 mL. Cytochrome P450 BM3 production was induced by the addition of 
IPTG. High cell densities of E. coli were obtained. Spectrophotometry and light 
microscopy were used to record the biomass. Cells from complex media were harvested, 
ruptured and an attempt made to purify P450 BM3 by affinity chromatography. 
P450 BM3 was detected using spectrophotometric and catalytic techniques.
5.3 Materials
5.3.1 Source of E. coli
Stocks of transformed E. coli XL-1 Blue (pJM25) were obtained from Dr. A.W. Munro 
(University of Edinburgh) as colonies on solid (LB.ampicillin) media.
5.3.2 Solid media
13 g/L LB Agar, Miller (Sigma chemical Co., UK), 50 pg/mL ampicillin in RO water was 
autoclaved (121 °C, 20min.) and 30 mL of the autoclaved solution poured into each petri
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dishes. Solid media was left to cool and incubated at 30 °C for 5 days. Contaminated 
plates were discarded.
5.3.3 Liquid media
24 g/L LB broth, Miller, (Sigma), 50 pg/mL ampicillin was autoclaved (121 °C, 20 min).
5.3.4 Chromatography
Ion Exchange Chromatography was achieved using fast protein liquid chromatography 
(FPLC) apparatus (Pharmacia Biotech, Sweden). A P-l variable speed pump was used to 
load and elute the protein sample from the DEAE Sephadex A-25 cation exchange matrix. 
The samples were collected by a fraction collector (Pharmacia FRAC 100).
5.3.5 Affinity Chromatography
2’,5* ADP sepharose (Sigma, UK) was used in the affinity separation of P450 BM3.
5.3.6 Gel filtration Chromatography
Size exclusion chromatography was used in the final step to concentrate the sample of 
P450 BM3.
5.3.7 Spectrophotometry
UV spectra, spectrophotometric assays and absorbance readings were recorded (ATI 
Unicam UV2 UV/vis photospectrometer). A water bath and immersion thermostat (VFK 
provided Grant, UK) temperature regulation.
5.3.8 Light microscopy
A light microscope (Olympus CH) was used for all microscopy work. Growing 
microorganisms were viewed (D Plan 100 oil optic) with an overall magnification of 
lOOOx. Cedar wood oil was used to lubricate the lens and the cover plate.
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5.3.9 Buffers
All buffers used are summarised bellow (Table 5-1).
Buffer Buffer Components
A 50 mM Tris, pH 7.25
B 10 mM potassium phosphate, pH 7.7
C 100 mM potassium phosphate, pH 7.7
D 200 mM potassium phosphate, 2’5’-AMP, pH 7.7
all buffers 2 mM P-mecaptoethanol, 1 mM leupeptin, 1 mM EDTA, 1 mM 
PMSF,
Table 5-1 Buffers used in the harvesting of E. coli and the down stream 
processing of P450 BM3
5.4 Methods
5.4.1 Solid media and maintenance of E. coli
E. coli, DH5a/pBM25 was obtained as a one week old culture on LB.ampilcillin agar. 
Glycerol stocks of colonies were added to 20% (w/v) glycerol and stored at -70 °C. Fresh 
cultures of E. coli were taken from frozen stocks and grown on solid LB agar with 50 p 
g/mL ampicillin.
5.4.2 Shake flask fermentation
Cultures (5 mL) were produced from a colony of E. coli from a solid media culture 
incubated for 4 days at room temperature. A line of E. coli was required to inoculate 
LB.ampicillin broth (100 mL) in a 500 mL baffled shake flask. Cells of E. coli were then 
incubated (37°C, 200RPM). The production of P450 BM3 was induced by the addition of 
IPTG when an was between 0.3 and 0.7. After the addition of ampicillin the 
incubation temperature was reduced to 30 °C.
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5.4.3 Induction of P450 BM3
The E. coli clone obtained (DH5a/pBM25) contained the IPTG inducible lac promoter. 
P450 BM3 production was promoted by the addition of IPTG to a final concentration of 
500 (ig/mL.
5.4.4 Cell Harvest
Cells of E. coli were harvested for 15 hr after the addition of ampicillin. The cells were 
centrifuged at 10,000g (JA2 MI Beckman, UK) for 20 min for 4 °C. This was adequate for 
producing a clear cell free supernatant. The cell pellet from centrifugation was suspended 
in buffer A (Table 5-1) and centrifugated (10,000g) to produce clean cell pellet free from 
growth media. Cells were stored at -20 °C until further use.
5.4.5 Cell rupture by freeze thaw cycle and sonication
The use of homogenisation as in the previous section caused a high concentration of 
fragmented DNA to be released into the supernatant. This material proved difficult to 
remove and so the use of an alternative method of cell rupture that did not cause DNA 
fragmenting was found. The effect of freezing and thawing followed by sonication was 
tested. Compacted cells suspended in buffer A (Table 5-1), at 4 °C. They were frozen 
and thawed twice to disrupt the cell membrane, and were then sonicated at 4 °C for 10 
min.
5.4.6 Cell free extract
Cell debri was removed from the protein extract by centrifugation (10,000g, 20 min. 4°C, 
Beckman J2MI).
5.4.7 Ammonium sulphate precipitation
Ammonium sulphate [(NPL^SOJ precipitation was used to produce a fractional 
precipitation of cell proteins. Ammonium sulphate was chosen because it; causes the 
precipitation of most proteins and it does not have a large heat of solution, so that the heat 
generated is low and easily dissipated. Even a 4.04 M saturated solution (20 °C) has a low
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density (1.24 g/cm ) therefore it does not interfere with the sedimentation of most 
precipitated proteins by centrifugation and its concentrated solutions prevent or limit most 
bacterial growth and in solution it protects many proteins from denaturation.
The volume of protein was determined and the solution placed on ice. Solid ammonium 
sulphate was then added (with stirring over a period of 2  min) to a final solution 
concentration of 30% (w/v). The use of a magnetic plate and flea was found to be 
necessary to reduce concentration gradients of ammonium sulphate within the vessel 
during the addition. After 20 min. the supernatant was removed from the precipitate by 
centrifugation (10,000g, 20 min. 4 °C) and poured into a ice cold beaker. Further 
ammonium sulphate was added to a final concentration of 60% (w/v). After 20 min. the 
solution was discarded and the pellet corresponding to the 30% to 60% (w/v) ammonium 
sulphate fraction was recovered. Solid fractions were stored at -20 °C until use.
5.4.8 Dialysis
Ammonium sulphate pellets were suspended in a small volume of buffer A (Table 4-1). 
To reduce the ionic strength of the protein solution, dialysis against buffer A (Table 4-1) 
was required. Space in the dialysis tubing (12,000 RMM cut off, BDH, UK) was required 
to allow for the increase in volume inside the tubing. Insoluble material was removed 
from the sample by centrifugation (20,000g, 20 min., 4 °C).
5.4.9 Ion Exchange Chromatography
An Ion Exchange Column (DEAE Sephacel, 100 mL, Sigma) was equilibrated with buffer 
A (200 mL) (Table 5-1). The supernatant produced by dialysis was then loaded onto the 
column manually. The non-binding proteins were then removed from the column by the 
addition of buffer A (200 mL) (Table 5-1) at a rate of 1 mL/min. To elute bound proteins, 
a 500 mL gradient of KC1 (0-500 mM) was used in buffer A (Table 5-1). Fractions were 
collected and the A450 recorded (Figure 5-1).
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5.4.10 Ultrafiltration
Peak fractions (dark red colour) obtained by Ion Exchange chromatography were 
concentrated using ultrafiltration. Centriprep microseparator with 30,000 RMM cut off 
(Amicon, UK) were used.
5.4.11 Affinity Chromatography
A 2 \5’ ADP sepharose column matrix (Sigma, UK) was used in the affinity separation of 
P450BM3. 40 mL of column matrix contained in a FPLC column (HR 10/30, [1 x 
20 cm], Pharmacia Biotech, Sweden). Buffer B (100 mL) (Table 5-1) was used to 
equilibrate the column. Concentrated protein was then added to the column at a rate of 
2mL/min. and the column washed with of buffer B (100 mL) (Table 5-1). Buffer C 
(40 mL) (Table 5-1) was used to remove material with an ionic interaction to the matrix. 
Protein was eluted from the column by the addition of buffer D (80 mL) (Table 5-1).
5.4.12 Spectrophotometry assay of P450 material
The yield of each step of the purification process was recorded by measurements of the 
Soret band of the sample at A418 using e = 143/mM/cm (Figure 5-1). (Black et a l, 1994).
5.4.13 Measurement of the P450 concentration
The concentration of cytochrome P450 was determined as described in the literature 
(Narhi & Fulco, 1987). Reduced spectra of the sample were obtained by the addition of 
2-3mg of solid sodium dithionite (Na2S2(>4) (Figure 5-1). A mixture of carbon monoxide 
(CO), and nitrogen (N2), was gently bubbled through a sample of dithionite reduced 
protein solution for 1 min and the spectra recorded (Figure 5-1). This was sufficient to 
saturate the sample with gas. Difference spectra were obtained by the difference in the 
spectra of the dithionite reduced and reduced CO bound spectra.
The concentration of P450 protein could be determined from the absorbance at A450 from 
the difference spectra using e = 91/mM/cm (Narhi & Fulco, 1992).
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5.4.14 Substrate binding
The effect of fatty acid substrate on the spectrum of the oxidised form of P450 BM3 was 
tested. The spectra of purified P450 BM3, was obtained in buffer A. Sodium laurate was 
added to a final concentration of 500 pM and the spectra repeated. A difference spectra 
was obtained by the difference of the two spectra (Figure 5-2).
5.4.15 Catalytic assay for P450 BM3
5.4.15.1 Reduction of NADPH
The reduction of NADPH was monitored in a 1 cm glass cuvette at 340 nm. A 40 nM 
solution of purified P450 BM3 was added to 200pM NADPH, in 100 mM potassium 
phosphate pH 7.7. Sodium laurate (100 mL) was then added to a final concentration of 
250 pM and a final volume of 1.5 mL. The rate of reaction was monitored spectro- 
photometrically at A340.
5.4.15.2 Gas chromatography (GC)
GC was used to determine the rate of substrate (sodium laurate) loss and the rate of the 
production of the hydroxy product
5.5 Results
5.5.1 Growth of E. coli on LB.ampicillin
Good growth was observed using the LB.ampicillin media. After 5 days on solid media, 
large colonies were formed. On liquid media exponential growth phase occurred within 
5 hr. Stationary growth phase was observed at 48 hr. Cells of E. coli were harvested 
before the onset of stationary phase as this was thought to result in a decrease in 
P450BM3 yield. The antibiotic ampicillin added to the media prevented growth of 
opportunistic organisms. These may have infected the culture and compete with the 
ampicillin resistant E. coli used. Expression of P450 BM3 decreased rapidly from cultures 
stored at 4 °C. For this reason the technique of sub-culturing was not used. Cultures of
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E. coli were taken from 20% (w/v) glycerol stocks stored at -70 °C. Reduction in 
expression was attributed to plasmid loss.
5.5.2 Storage of purified P450 BM3
When the concentration of P450 BM3 in the sample was recorded, the solution was stored 
in sterile glycerol (20% (w/v))
5.5.3 Spectra
Production of cytochrome P450 was induced by the addition of IPTG to a final 
concentration of 500 pg/mL. The spectrum of the oxidised form of the protein was first 
recorded, the sample treated with dithionite, and the spectrum of the reduced protein was 
taken. Finally, the reduced protein was bubbled with CO for 1 min and the reduced CO 
bound spectrum was recorded.
The spectra of the sample oxidised with the addition of IPTG, has absorbance maxima at 
390 and 420 nm (Figure 5-1). This is a characteristic Tow spin’ spectrum for a P450 
Cytochrome. The spectra of the sample reduced with dithionite, has a single absorbance 
maxima at 410 nm (Figure 5-1). This is a characteristic ‘high-spin’ spectrum for a P450 
Cytochrome. The spectrum of the sample first reduced with dithionite, then bubbled with 
CO has a strong absorbance at 450 nm (Figure 5-1). This is characteristic of the reduced 
CO spectrum of a purified sample of a cytochrome P450.
The three spectra (Figure 5-1) indicate that the sample is has a high concentration of 
Cytochrome P450.
The spectra of purified P450 BM3, was obtained in buffer A. Sodium laurate was added 
to a final concentration of 500 pM and the spectra obtained. The ‘difference spectra’ was 
obtained by the plotting numerical difference of the absorbance at each wavelength the 
two spectra (Figure 5-2).
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5.5.4 Spectral characteristics
The oxidised, reduced and the reduced CO bound spectra of this protein has absorption 
maxima corresponding to other P450 enzymes but in particular correspond exactly to 
cytochrome P450 BM3 (Narhi & Fulco, 1992). The oxidised form has an absorbance 
peak at 418 nm and a shoulder at 394 nm. This corresponds to iron in the ferric (Feffl) 
form in the heme. A418 corresponds to low spin (hexacoordinate) form of iron and A394 
corresponds to iron in the high spin (pentacoordinate) form. Both peaks can be seen in the 
oxidised form indicating that the heme is only partially oxidised. The reduced form of 
P450 BM3 had an absorbance profile maxima at A418.
5.6 Conclusions
The production and isolation of P450 BM3 from E. coli cloned for its expression was a 
superior method when compared to the natural organism B. megaterium. P450 BM3 was 
isolated and purified to high purity when determined spectrophotometrically.
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Figure 5-1 The spectra of purified cytochrome P450BM3 from transformed 
E. coli DH5a/pBM25.
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Figure 5-2 Effect of fatty acid substrate on the spectrum of the oxidised form 
of P450 BM3 (the difference spectra of purified P450 BM3
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6. Effect of n-alcohols on the activity of 
cytochrome P450 BM3
6.1 Abstract
A series of primary alcohols from methanol to hexanol inhibits the activity of the 
catalytically self-sufficient cytochrome P450 BM3. The rate of inhibition of the 
hydroxylation of sodium dodecanoate increases with increasing potency as the molecular 
weight of the w-alcholol increases. The ability of ^ -alcohols to reduce the activity by 50% 
is limited to the first five members (C1-C5) of the group. This is due to the decreasing 
solubility of the alcohols in water. The aqueous concentration of solvent required for 
inhibition is of the same order as that required to inhibit the membrane bound hydroxylase 
from R. stolonifer.
6.2 Introduction
The effect of ^ -alcohols on the purified soluble P450 BM3 from B. megaterium can yield 
information about the direct effect of solvents on a P450 protein with similar structure to 
membrane bound P450 proteins.
B. megaterium has been identified as a source of soluble P450 (Section 1). E. coli 
transformed for the production of P450 BM3 has been cultivated in liquid media to 
produce high amounts of the enzyme P450 BM3 (Section 5). P450 BM3 has been purified 
to a concentration of 114 pM, 13.6g/L determined from the Soret band of the sample at 
A450-490, using s = 91/mM/cm (Black et a l 1994). This enzyme will now be used in the 
hydroxylation of lauric acid. The effect of w-alcohols on the initial rate of the 
hydroxylation will be investigated. Earlier work suggests that the membrane bound P450 
enzyme (P45011oc) in R. stolonifer is inhibited when the concentration of a series of 
primary alcohols reaches a critical molar concentration in the membranes. In this work we 
have tested the effect of these alcohols on the activity of the soluble hydroxylase 
cytochrome P450 BM3 which is naturally present in B. megaterium. P450 BM3 has a
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similar structure as the one described in R. stolonifer but it is not membrane associated. It 
can therefore be used to determine the direct effects of the alcohols on a cytochrome P450 
without any complicating effects arising form the membranes.
6.3 Materials
Methanol, ethanol, propanol, ^-butanol, H-pentanol and w-hexanol analytical grade (Sigma 
Chemical Company, UK). p-NADPH was obtained as the tetra-sodium salt (Sigma, UK). 
Sodium laurate (Sigma, UK) was stored as a 2 mM stock solution, pH 7.8 at 4°C.
6.3.1 Protein handling
Cytochrome P450 BM3 was prepared as a concentrated solution in a 100 mM Phosphate 
buffer, with glycerol 20% (v/v) pH 7.5 (Section 5). The enzyme was stored at -20°C until 
used at a concentration of 11.4 nM.
6.3.2 Spectroscopy
UV spectra, spectrophotometric assays and absorbance readings were performed (ATI
(E)Unicam UV2 -100 spectrometer) using standard 1 mL quartz glass cuvettes (Hellma , 
UK). NADPH-dependant fatty acid hydroxylation was measured at 37 °C in 100 mM 
phosphate buffer containing 200 pM sodium laurate and 100 pM NADPH (£340, 6.2 mM'1 
cm'1).
When alcohols were added to acrylic cuvettes, the surface of the cuvettes turned opaque. 
Quartz cuvettes were to be resistant to alcohols and were used in the spectrophotometric 
measurements.
6.3.3 Assay development
6.3.3.1 Laurie acid
Laurie acid was found to have a solubility of 300 pM when dissolved in water to yield a 
solution of pH 4.0. The sodium salt is soluble to 2 mM yielding a solution of pH 7.0. The 
increased solubility of sodium laurate reflects the increased tendency of Na+ ions to
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dissociate relative to H+ ions. The solubility of lauric acid increases with the pH of 
solution since this shifts the equilibrium (Equation 6-1) to the production of the ionised 
acid. This equilibrium has been found to be slow therefore great care was taken in 
producing solutions of fatty acids.
Equation 6-1 The two states of long chain fatty acids
The presence of ions in solution decreases the solubility of sodium laurate therefore a 
stock solution of 2 mM in water was used.
6.3.3.2 NADPH
NADPH is only stable when in a dry form. Stability increases as temperature decreases 
and -70 °C was found to stabilise the reduced form.
Rate of sodium laurate hydroxylation in the absence of NADPH is negligibly slow 
compared to the rate of reaction in the presence of NADPH (Equation 6-2).
6.3.3.3 Kinetics of the reaction
The concentrations of substrates were chosen such that the loss of substrate had no 
measurable effect on the activity over the range of measurement. The effect of lauric acid 
concentration on the initial rate was also tested, and initial activities were found to exhibit 
classic Michaelis-Menten kinetics. The Km value for the hydroxylation of lauric acid 
under the conditions chosen was about 73 pM (Figure 6-1).
free acid
i
+
ionised acid
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Prefered site 
of oxidation
'C 02‘ + 0 2 + NADPH
cyt P450BM3
OH
+ H20  + NADPH
Equation 6-2 The (co-2) hydroxylation of sodium laurate
6.3.3.4 Effect of pH on the activity
The effect of pH was investigated with the addition of strong acid (HCL) and strong base 
(NaOH). The activity of P450 BM3 was found to describe the classic bell shaped curve. 
The maximum hydroxylase activity was at pH 7.5 (Figure 6-2).
6.3.3.5 Ionic strength
The effect of ionic strength was tested using a range of of potassium phosphate 
concentrations in the range up to 200 mM. The hydroxylase activity increased with the 
ionic strength, most activity was recorded at a concentration of 100 mM. At higher 
concentrations of phosphate, the hydroxylase activity decreased (Figure 6-3).
The non-specific depletion of NADPH catalysed by water in 100 mM phosphate buffer 
P450 BM3 and alcohol was shown to be undetectable at (A340). Ester formation from the 
reaction of lauric acid and alcohol was not investigated and it is thought to be unlikely at 
neutral pH.
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6.3.3.6 Oxidation of alcohols
Alcohols may oxidise NADPH, effectively removing NADPH from the reaction mixture. 
Since we are measuring the reduction of NADPH to determine the rate of hydroxylation 
the concentration of NADPH was measured in the presence of alcohol without sodium 
laurate. At the concentrations used in the hydroxylation experiments no reduction of 
NADPH was detected.
At the experimental concentrations there was no detectable de-coupled oxidation of 
(alcohol oxidation) NADPH, was measured in the absence of sodium laurate.
Ascending the homologous series of alcohols the solubility decreases (Table 6-1). As the 
chain length increased the concentration of alcohol required to inhibit P450 BM3 quickly 
rose to that of the same order of the maximum solubility in water. A saturated solution of 
pentanol was used to inhibit the reaction by 50%. Saturated solutions were obtained by 
mixing an excess of alcohol with water to produce a liquid two-phase system. A syringe 
(Hamilton, UK) was used to remove a sample of alcohol in water. This solution was 
tested for its ability to inhibit the hydroxylation activity at fixed time intervals after 
mixing. It was found that the partitioning was equilibrated after 2 min of mixing for 
pentanol.
/i-alcohol Density
(g/mL)
Poet Maximum aqueous solubility 
(M)
Methanol 0.7914 -0.76 32
Ethanol 0.7893 -0.24 1 0
Propanol 0.8035 0.28 3.2
Butanol 0.8098 0.80 1 .0
Pentanol 0.8144 1.30 0.250
Hexanol 0.8136 1 .8 0.0501
Table 6-1 Solubility of w-alcohols in water at 25 °C (Bell, 1972).
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6.3.4 mechanics of the hydroxylation assay
Sodium laurate was prepared as a 2 mM stock solution in water and used within one day. 
NADPH was prepared from dry stock at -70 °C to a concentration of 15 mM and kept on 
ice. It was found that the activity of P450 BM3 decreased rapidly when stored at low 
concentrations. Therefore was important to keep the concentration of P450 BM3 high until 
required. P450 BM3 was used in the assay at a final concentration of 11.4 nM. 
P450 BM3 concentrate (114 pM) was removed from -20 °C storage, diluted to 1.14 pM to 
produce stock solutions that was stored on ice and used within one day.
It was found that the injection of concentrated P450 BM3 to activate hydroxylation gave 
unreliable kinetics because of the high viscosity of the glycerol in the enzyme solution. 
Therefore 10 pL of the stock solution (1.14 pM) was diluted to a final volume of 100 pL, 
in 100 mM phosphate buffer pH 7.5 to reduce the viscosity of the solution immediately 
before use.
It was also important to inject P450 BM3 in the same concentration of buffer as in the 
cuvette, since this promoted fast mixing and reproducible kinetics. The rate of 
hydroxylation of sodium laurate in the absence of alcohol over a period of 15 s was taken 
as 100% activity. Various quantities of alcohols were then added to the system and the 
effect on the initial activity recorded.
6.3.4.1 Standard procedure
1 M phosphate buffer (100 pL), RO water (1090 pL), 2 mM sodium laurate and 15 mM 
NADPH, (10 pL), was added to a 1.5 mL quartz cuvette and the initial A340 value recorded. 
Hydroxylation was then initiated by the addition of of 114 nM enzyme (100 pL) and the 
A340 recorded.
6.4 Results and Discussion
All the alcohols tested, inhibited the hydroxylation of sodium laurate (Figure 6-4). Their 
potency as inhibitors increased with their molecular weight (Figure 6 -6 ). Pentanol shows 
a 50 % inhibition at about O.lx the molar concentration at which methanol has a similar 
effect (63 mM and 0.7 M respectively) (Figure 6 -6 ).
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A saturated aqueous solution of hexanol inhibits the hydroxylation by about 25 %. A 
larger degree of inhibition is prevented because the hexanol to too insoluble to reach a 
sufficient concentration, of about 55 mM in the aqueous phase. Nevertheless it is clear 
from the data (Figure 6-6) that it is a more effective inhibitor than pentanol since there is a 
detectable loss of activity even at a concentration of 10 mM in the aqueous phase. None of 
the other alcohols inhibit the enzyme at this concentration.
The apparent Km for sodium laurate hydroxylation increases to about 150 |iM when the 
activity is measured in the presence of 0.7 M methanol, which is close to the IC50 value. 
There is a small decrease in Vmax, but the data does not differ significantly for that 
expected of a competitive inhibitor where the Kj (for methanol) is about 0.5 M.
In the previous experiments with the membrane bound hydroxylase from R. stolonifer, the 
aqueous concentration of methanol and pentanol necessary to inhibit the activity by 50% 
were about 2 M and 25 mM respectively (Munro et al. 1994). Although these figures are 
of the same order as the IC50 values for their inhibition of cytochrome P450 BM3 they are 
sufficiently different to warrant a more careful study of the former with techniques which 
measure the membrane concentrations of the solvents.
This can be achieved using whole cells of R. stolonifer and the methods developed in 
Section 2.
The concentration of alcohol required to inhibit hydroxylation by 50% (IC50) was recorded 
for all alcohols. The average of three experiments is shown (Table 6-2).
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tt-alcohol Log(io) IC 50 IC 50 (mM) Log(io) solubility Solubility (M)
Methanol -0.15 708 32 32
Ethanol -0.35 447 1 10
Propanol -0.78 166 0.51 3.2
Butanol -1.05 89.1 0.00 1.0
Pentanol -1.20 63.1 -0.60 0.25
Hexanol -1.26 55.0 -1.30 0.0501
Table 6-2 Comparison of IC50 concentrations of alcohols and maximum 
solubility of alcohols in water. Figures in italic are predicted values based on 
experimental results.
As the homologous series is ascended from Ci to C6 the values of IC50 decrease and the 
toxicity increases. Hexanol inhibits the hydroxylation but the concentration required for 
IC50 (approx. 55 mM) is above the maximum solubility in water. The presence of 
phosphate ions limited the solubility even further.
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Figure 6-1 Effect of Sodium laurate concentration on the initial activity of 
P450 BM3.
Assay conditions: 11.4nM Cytochrome P450BM3, sodium laurate, in a 
100 mM potassium phosphate solution, pH 7.5. Values of V m a x  (0.18 
Units/min) and Km (73 pM) were obtained using standard fitting function of a 
rectangular hyperbola with no weighing.
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Figure 6-2 Effect of pH, on the initial activity of P450 BM3.
Assay conditions: 14 nM P450 BM3, 200 pM sodium laurate, in a lOOmM 
potassium phosphate solution.
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Figure 6-3 Effect of ionic strength of the solution on the initial activity of 
P450 BM3.
Assay conditions: 11.4 nM P450 BM3, 200 pM sodium laurate, in a potassium 
phosphate solution, pH 7.5.
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Figure 6-4 The effect of methanol on the initial activity of hydroxylation. 
Assay conditions: as for Figure 6-1 with the addition of 700 mM of methanol. 
This corresponds to I C 5 0  with 100 mM sodium laurate.
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Figure 6-5 Effect of w-alcohols on the rate of sodium laurate hydroxylation. 
Assay conditions: 11.4nM P450 BM3, 200 pM sodium laurate, and 100 pM 
NADPH in a solution of 100 mM potassium phosphate buffer, pH 7.5.
Alcohols ( ■  ) methanol, ( •  ) ethanol, ( A ) propanol, ( ▼ ) butanol, ( ♦ ) 
pentanol, ( + ) hexanol.
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Figure 6 - 6  The inhibition of P450 BM3 with alcohols of increasing chain 
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7. Hydroxylation of progesterone by whole 
cells of Rhizopus stolonifer
7.1 Abstract
(1) Whole cells of R. stolonifer were grown on solid and liquid potato dextrose media.
(2) The induction of P45011a with progesterone was determined at various times during 
the incubation.
(3) The production of P4501 l a  was found to be independent of the time of induction.
(4) The effect of the time of induction on the final biomass on the culture was low at the 
concentration used to give good expression.
7.2 Introduction
The specific hydroxylation of progesterone to lla-hydroxyprogesterone can be catalysed 
by the monooxygenase system P4501 l a  in R. stolonifer (Sonomoto, Nomura, Tanaka, et 
al., 1982). The resolution of this hydroxylase into its three components and a subsequent 
reconstitution of the complete electron transports chain (Breskvar, et aL, 1987), showed 
that P45011a is a class I cytochrome P450 when characterised in terms of its redox 
partner (Ravichandran et al., 1993).
It has been shown that P4501 l a  is induced in R . stolonifer as a defence mechanism with 
hydroxy-progesterone excreted from the fungi (Breskvar et al., 1995). The microsomal 
fraction of the mitochondrial membranes of R. stolonifer has been purified. Cytochrome 
P45011a has been reconstituted and shown to have simular activity as whole cells of 
R. stolonifer (Breskvar et al., 1987). However the actual activity was measured by the 
reduction of NADPH and this contrasts with previous work (Hanisch, 1978), where no 
P45011a activity was found in microsomal preparations as determined by the 
transformation of progesterone to hydroxyprogesterone.
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The effect of aqueous concentrations of 77-alcohols on P45011oc activity has been 
determined by the final concentration of hydroxyprogesterone over a 24 hr whole cell 
incubation period (Osborne, 1990). The activity of P45011a would be best observed 
during the initial reaction period, so that at a latter stage the effect of 72-alcohols on the 
initial activity can be seen.
In these experiments whole cells of R. stolonifer will be grown to a suitable biomass and 
the induction of active P4501 l a  investigated with the addition of progesterone. The rate 
of conversion of progesterone to 1 l a  hydroxyprogesterone by whole cells of R. stolonifer 
will be followed by HPLC during the reaction (Osborne, 1992).
7.3 Materials
7.3.1 HPLC equipment
A Sperisorb Octyl 5 pm HPLC column was used for all steroid analysis (Sigma Chemical 
Co., Poole, UK). A Cg reverse phase 1 cm guard column (Phase Separations) pre column 
was used to protect the main analytical column from damage and was changed after 2000 
operations.
7.3.2 Buffers and Media
Buffer A: 50 mM potassium phosphate buffer pH 7.5 with 1.5 mM MgCL.
Potato dextrose agar (PDA), potato dextrose broth (PDB), progesterone and lla-hydroxy- 
progesterone were obtained from Sigma Chemical Co., Poole, UK.
24 g/L PDA and 24 g/L PDB were used to cultivate R. stolonifer in solid and liquid phase 
respectively.
7.4 Methods
7.4.1 Organism
R. stolonifer ATCC 622b was obtained from Glaxo Welcome Group Research.
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7.4.2 growth conditions
Cultures of R. stolonifer were obtained by the inoculation of PDA until heavy sporulation 
was noted. Sterile separation of spores from mycelia was achieved using a nylon mesh 
into a volume of water. Spore suspensions were counted using a heamocytometer 
counting chamber and centrifuged at 50,000 g  for 1 hr (Beckman J2-MI ultracentrifuge). 
A known quantity of spores was used as inocula for 100 mL of PDB in 500 mL baffled 
flasks. Flasks and reaction vessels were all coated with (Sigma cote®, Sigma) before use. 
The pH of PDB was adjusted to 4.5 using phosphoric acid and steam sterilised (Denley 
BA852 Sovereign portable autoclave) at 121 °C for 20 min. Production of R. stolonifer 
was performed in an incubated shaker for 18 hr at 200 RPM, 28 °C.
7.4.3 Induction and harvesting
Progesterone was added to induce P4501 l a  production at various times dining the growth. 
The cells were harvested after 18 hr using a nylon mesh and washed with 1 L of buffer A 
(Section 7.3) until the eluent was clear.
7.4.4 Determination of biomass
Cells from 100 mL cultures were filtered through a Buchner funnel with Whatman filter 
paper for 3 min. The filtered cells were weighed (wwt) and oven dried at a temperature of 
70 °C until constant weight (dwt). The dwt/wwt ratio was taken to be the ratio of the 
weight of cells before and after oven drying.
7.4.5 HPLC sample preparation
400 pL Samples of cell suspension were taken throughout the incubation and 50 mM 
hydrochloric acid (10 (iL), was added to the samples to stop any reaction and precipitate 
cell debris. Acidified samples were spun for 1 min at 13,000 RPM. IOjiL aliquots of 
supernatant were then added to 990 pL of mobile phase (Table 7-1). These samples were 
analysed for progesterone and hydroxy-progesterone.
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Component Setting
Mobile phase methanol/water (80:20 v/v)
Pressure 1000 p.s.i.
Flow rate 1.4 mL/min
loop volume 50 pL
Temperature 20 °C
Detection X 254 nm
Separation time 4 min.
Table 7-1 HPLC conditions for the detection of progesterone and 11a- 
hydroxy-progesterone
7.4.6 Assay of P45011a activity
A spectrophotometric scan of progesterone and lla-hydroxyprogesterone showed that the 
maximum absorbance occurs at 254 nm. 50 pL samples of reaction media, dissolved in to 
mobile phase (2 mL), were assayed using a reverse phase HPLC (Table 7-1).
7.5 Results
7.5.1 flask preparation
Osborne (1990) used flasks that had been coated with silicon to prevent fungi adhering to 
the vessel. This was found to be very important as the glassware that had not been treated 
with silicon proved to be a good anchor for growth, allowing the culture to be removed 
from solution
7.5.2 Inocula levels
Osborne (1990) reported two types of growth forms. Filamentous growth was obtained
o  / r
by inoculation in 1 L of culture medium with 5x10 spores, 500x10 spores/L. Pelleted
o
growth however, occurred at an inoculum dose of 1.7x10 spores in 0.75 L of culture
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medium, 230xl06 spores/L. Although where spores inoculum ranged from 0.2x106 to 
60x106 spores/L no pelletted growth was observed.
Low spore levels resulted in long and variable lag phases preventing growth in some cases 
(Figure 7-1).
Initial inocula of 15xl06 spores/L gave reproducible growth with no signs of a variable lag 
phase. One plate of mature culture can yield up to 3xl06 spores and so this lower inocula 
was useful since one 10 day incubation of R. stolonifer on PDA could give enough spores 
for one inoculation of 0.2 L of liquid culture. In contrast the method developed by 
Osbome requires 500x10 sp./L. This corresponds to 12 petri dishes of R. stolonifer for 
0.1 L of culture. Spores at a concentration of 15xl06 spores/L were used to inoculate 
cultures in all further work.
7.5.3 Effect of media concentration
The effect of substrate concentration on the growth characteristics was determined for 
PDB media. It was found that 24 g/L PDB produced a high biomass yield when compared 
to the concentration of PDB (Figures 7-2 & 7-3).
7.5.4 development of induction protocol
To induce the production of P45011a Osborne (1993), used 2 g/L progesterone 
(6.36 mM). However progesterone, is not soluble at this concentration in buffer A 
(Section 5.3). The effect of the induction time and amount of progesterone on the final 
biomass and the activity of P4501 l a  were not documented in the thesis.
It was initially assumed that only progesterone in the aqueous phase would promote the 
induction of P4501 l a  and act as a substrate. Thus the excess progesterone that existed in 
the solid phase would be unnecessary and therefore an investigation into the solubility of 
progesterone in a range of media was explored (Table 7-2). Aqueous progesterone levels 
were obtained by producing an excess solution of progesterone. A sample of the solution 
was removed, filtered and assayed for progesterone using HPLC (Table 7-1).
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Media Maximum solubility (g/L)
2 mM Potassium phosphate buffer 0.38
10 mM Potassium phosphate buffer 0.09
20 mM Potassium phosphate buffer 0.05
50 mM Potassium phosphate buffer 0.02
Buffer A (Section 7.3) 0.01
PDB 0.02
Table 7-2 Solubility of progesterone in various media.
7.5.4.1 Effect of progesterone concentration on induction of P450 11a
Induction at 16 hr into the incubation with 0.01 g/L progesterone resulted in undetectable 
activity of the conversion of progesterone to hydroxyprogesterone by HPLC (Perkin Elmer 
HPLC detector).
For detectable induction of P45011a the concentration of progesterone required was 
found to be at least 1 g/L, a concentration of 2 g/L resulted in excellent and reliable 
induction. An aqueous solution of 2 g/L Progesterone appears as a heterogeneous 
suspension.
7.5.4.2 Effect of induction time on biomass and P45011a activity
The production of P450 11a was induced by the addition of progesterone (Osborne, 
1990), while R. stolonifer was in the growth phase, (16 hr after inoculation). Incubation of 
growing cells for 2 hr resulted in whole cells that had measurable P450 1 l a  activity. Cells 
of R. stolonifer were harvested at 18 hr. The effect of induction time on the final biomass 
was not documented in Osborne’s work, hence, the effect of induction time on the level of 
induction and the effect of biomass was determined in this work.
Progesterone was added to the cultures of R. stolonifer at different time intervals during 
the growth phase. After 18 hr the cells were harvested, washed, dried and weighed.
The addition of progesterone was found to reduce the final biomass of the culture 
(Figure 7.4). This reduction is typically 20 % (dwt) and the reduction is independent of
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the time range tested. The activity of P450 11a was unaffected by the addition of 
progesterone early in the fermentation
7.5.5 determination of biomass
Wet weight of a 100 mL of culture of R. stolonifer was found to be 2.4 ±0.1 g (wwt). Dry 
weight analysis showed that ~6 % of the wet weight was biomass (dwt).
7.6 Conclusions and Discussion
From the results presented it is evident that the concentration of progesterone used to 
induce production of P450 1 l a  and the concentration of progesterone in the bioconversion 
media has a strong influence on the hydroxylation of progesterone with 11a- hydroxylase 
in R. stolonifer.
The activity of P450 1 l a  was found to be higher when higher amount of progesterone was 
used. The induction of progesterone 11a hydroxylase could be initiated in the growing 
phase and in the resting phase where no growth occurs. This indicates that the production 
of P450 11a hydroxylase activity is a highly evolved mechanism. In all cases a delay in 
activation was seen which could be a result of progesterone partitioning from the media in 
to the lipid membranes oiR. stolonifer.
2 g/L Progesterone appeared as an un-dissolved suspension in buffer A. This solid 
suspension appeared to be essential in the induction of activity. Solid progesterone must 
partition into the bio-membranes of R. stolonifer to initiate activation. The ability to 
induce P450 11a activity at the start of the inoculation resulted in a higher experimental 
turnover.
This observation could be relevant in a production environment. Progesterone did exert 
some growth inhibition. The small reduction in final biomass also indicates that the 
progesterone in not highly toxic and adds to the evidence that the R. stolonifer has an 
efficient detoxification mechanism for the removal of this steroid.
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7.6.1 Assay of progesterone lla-hydroxylase activity
It was found that the concentration of progesterone could not be determined accurately 
using pipette sampling and this was attributed to the heterogeneous nature of the 
incubation media. It was found that the hydroxyprogesterone had a higher solubility in the 
aqueous phase and hence the rate of the hydroxylation reaction was determined by the 
production of hydroxyprogesterone (Figure 7.5). The concentration of progesterone used 
to induce P450 11a activity and the concentration of progesterone in the incubation media 
was found to have an effect on the initial rate of the reaction. A lag phase appeared when 
a higher concentration of progesterone was used in the incubation broth than used to 
induce P450 11a activity (Figure 7.5). R. stolonifer displayed P450 11a activity even 
when not induced within the fermentation. When the concentrations of progesterone in the 
induction period and during incubation were equal no lag phase was seen (Figure 7.6). It 
appears that the low level of progesterone (0.2 g/L) is insufficient to induce the 
hydroxylase activity to its maximum potential, and that further induction occurs during the 
assay.
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Figure 7-1 Comparison of final cell weight and spores inoculum levels.
Results for R. stolonifer culture in of 24 g/L PDB (100m L), after 24 hr at 28 ° 
C and 200 RPM.
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Figure 7-2 Effect of the concentration of PDB on the R. stolonifer yield.
Yield is as expressed as the dwt compared with the weight of PDB. Data is 
from three 100 mL fermentations. Initial inocula concentration of 15xl06 
sp./L was used.
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Figure 7-3 Effect of R. stolonifer yield, expressed as the dry cell weight as a 
percentage of PDB.
Initial inocula concentration of 15 x 106 sp./L.
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Figure 7-4 Effect of induction time with 2 g/L progesterone, on the biomass of 
R. stolonifer at 18 hr of incubation in PDB. Biomass is expressed, as dwt as a 
percentage of control were no progesterone was added.
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Figure 7-5 The Biotransformation of 2 g/L Progesterone to Hydroxy­
progesterone.
Assay conditions: Incubation of R. stolonifer induced with 0.2 g/L
progesterone. The biotransformation of progesterone ( •  ), to 
hydroxyprogesterone ( ■  ) was followed by HPLC.
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Figure 7-6 The Biotransformation of Progesterone to Hydroxy-progesterone. 
Assay conditions: R. stolonifer induced with 2.0 g/L of progesterone was 
incubated with 2.0 g/L of progesterone ( ■  ). Biotransformation to 
hydroxyprogesterone ( •  ) was followed by HPLC
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8. Inhibition of whole cells of R. stolonifer with 
n-alcohols
8.1 Abstract
(1) The specific hydroxylation of progesterone to lla-hydroxyprogesterone was 
monitored in whole cells of R. stolonifer.
(2) The series of 72-alcohols from methanol to octanol inhibits the initial rate of the 
reaction with increasing potency as the molecular weight increases.
(3) The ability to inhibit the reaction by 50% (IC50) is limited to the first seven members 
of the homologous series.
8.2 Introduction
The specific hydroxylation of progesterone to lla-hydroxyprogesterone can be catalysed 
by the monooxygenase system P450 1 l a i n  R. stolonifer (Section 1), and is an example of 
a microbial biotransformation of a hydrophobic compound. The low solubility of substrate 
in the aqueous phase can cause mass transfer limitations and reduces the overall activity of 
the reaction. The use of methanol/aqueous co-solvent can be used to increase the catalytic 
activity, (Osborne et al., 1990). Two-phase systems however are inhibitory and the 77- 
alcohols from methanol to hexanol inhibits with increasing potency as the molecular 
weight increases (Osborne et al., 1992). In that study the conversion of progesterone was 
determined after 24 hr. The effect of 72-alcohols on the initial activity was not 
documented. The effect of solvent on Km and Vmax cannot be determined. In this 
investigation the initial rates of reaction will be documented and the effects of 77-alcohols 
(nCl-nC6) on the rate of reaction will be determined.
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8.3 Materials and Methods
Organism, growth conditions and induction were those documented earlier (Section 7).
8.3.1 Incubation of whole cells with alcohol
Harvested cells of R. stolonifer were re-suspended to a concentration of 10 g/L (wwt) in 
reaction mixture, containing 50 mM phosphate buffer pH 7.4, 2 g/L progesterone and 
various concentrations of w-alcohol to a final reaction volume of 20 mL. Incubations of 
whole cells and progesterone in alcohol solutions were performed in a shaker at 150 RPM, 
20 °C. The incubation was followed by HPLC (Section 7).
8.4 Results
8.4.1 Incubation of whole cells with alcohol
8.4.1.1 Development
MgCL and glucose were removed from the incubation buffer since the addition had no 
effect on activity over 24 hr in our preliminary experiments. The initial rate of reaction 
was measured over a period of 4 hr. When the concentration of progesterone used in 
incubation experiments was higher than the concentration used in induction experiments 
there was an extended period of low activity in the reaction vessel. When the incubation 
and induction concentrations were identical there was an immediate production of 
hydroxyprogesterone.
8.4.2 Inhibition with methanol
Each alcohol was added to the incubation medium in turn and the hydroxylation reaction 
was followed. The effect of alcohols on the rate of reaction was repeated for methanol to 
H-hexanol (Figure 8.1). The I C 5 0  values were estimated when the percentage enzyme 
activity remaining is plotted against the Logio.
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8.5 Discussion
From the results presented in Figure 8-2 it is evident that the chain length of the alcohol 
has a strong influence on the rate of hydroxylation of progesterone with 11a- hydroxylase 
of R. stolonifer. Values for IC50 and the Log P of the ^-alcohol are highly correlated 
(Figure 8-3). This confirms the result given earlier. The historical data shows a tendency 
to underestimate the IC50 concentrations for propanol to octanol. Indeed «-octanol was 
unable to inhibit the reaction to 50 % but a value of 5.4 mM is indicated. This is higher 
than the solubility limit in pure water, 3.2 mM. Methanol and ethanol however, were 
underestimated.
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Figure 8-1 Graph to show the effect of the total concentration of n-
alcohols in the system on the activity of P450 1 la .
Activity was measured as the rate of progesterone conversion to 
hydroxyprogesterone and was recorded as a percentage of that in the 
absence of alcohol. ( ■  ) methanol, ( •  ) ethanol, ( A  ) propanol, ( ▼ )
butanol, ( ♦ ) pentanol, ( + ) hexanol, ( X ) heptanol.
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Figure 8-2 Concentration of alcohol added to the system to achieve 50% 
inhibition of the R. stolonifer hydroxylase.
( ■  ) historic IC50 (Osborne et al., 1990). ( ▲ ) experimental IC50 ( •  ) solubility in 
moles/L Where the alcohol is miscible with water the data shows the molar 
concentration of the neat alcohol.
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9. Partitioning of solvents into whole cells of 
R. stolonifer
9.1 Abstract
(1) The partitioning of ^-alcohols in whole cells of R. stolonifer was monitored using the 
methods developed previously (Section 3).
(2) Alcohols from methanol to octanol were found to associate with cellular membranes of 
R. stolonifer to a fixed ratio.
(3) This amount of solvent was found to be similar for all the alcohols tested.
9.2 Introduction
The initial rate of the hydroxylation of progesterone to 11a hydroxy-progesterone by 
whole cells of R. stolonifer has been inhibited with w-alcohols. The ability to inhibit the 
reaction increases with the chain length of the alcohol (Section 8). The aqueous 
concentration of «-alcohol required to inhibit the reaction by 50 % (IC50) correlates well 
with the rt-octanol water partition coefficient (Log P) of each of the w-alcohols in the 
homologous series from methanol to heptanol (Section 8). The Log P and the membrane 
partition coefficient (Pmem) can also be related (Collander, 1951). Exact determinations of 
inhibiting solvents that are associated with the biological membrane phase however, to this 
date have not been obtained experimentally. They have been inferred from Log P and Log 
Pmem data and assume that they are related by a linear function (Seeman, 1972) or some 
power function (Collander, 1951). In this section exact concentrations of w-alcohols will 
be determined for whole cells of R. stolonifer using the solvent assay developed 
(Section 3). They will be correlated with the aqueous concentration data (IC50) obtained 
earlier (Section 8).
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9.3 Materials
Buffer A and liquid media PDB was used to cultivate cells of R. stolonifer as described 
earlier (Section 7.3).
9.3.1 Partitioning Media
1.25 M methanol, 1 M ethanol, 0.79 M propanol, 0.20 M butanol, 0.05 M pentanol, 
0.04 M hexanol and 0.0079 M heptanol were used to partition into whole cells of 
R. stolonifer. These were the apparent IC50 concentrations of the alcohols examined and 
are the total concentrations of the alcohols added to the incubation mixtures.
9.4 Methods
9.4.1 Organism, Growth and harvest conditions
Growth procedures were used as reported earlier (Section 7). A final fermentation step in 
2 L baffled shake flasks was used to produce the required cell biomass. Harvested cells 
were obtained using nylon mesh (Section 7).
9.4.2 Incubation of whole cells with /i-alcohols
0.4 g (wwt) of fresh R. stolonifer was added to partitioning media (40 mL). This is the 
same cell concentration (lOg/L) as was used in the measurement of progesterone 
hydroxylation. Samples (1 mL) were taken at time intervals and spun in a mini centrifuge 
(113 lab centrifuge Sigma, Germany) for 2 min. at 13,000 RPM.
9.4.3 Solvent assay
Samples of the supernatant were added to the solvent test mixture (Section 3.2), and the 
reaction recorded by luminescence (Section 3.1).
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9.5 Results
9.5.1 Effect of time on the partitioning of /i-alcohols tested.
9.5.1.1 Concentration of alcohol in the aqueous phase.
The concentration of alcohol in the aqueous phase was determined by using standard 
curves obtained earlier for the inhibition of luciferase by ^-alcohols (Section 3.3).
The results can be seen below (Table 9-1).
Carbon chain 
Length
[ROH^a/j]
mM
[R O H ^ i
mM
Amount per g of wet 
cells 
(10J Moles)
1 1250 1200 ---
2 1000 985 3.1
3 790 780 6.1
4 200 195 3.1
5 50 46 2.5
6 40 37 1.5
7 7.9 6 1.2
Table 9-1 The partitioning of ^-alcohols into cellular membranes o f  
R. stolonifer.
From this data it is possible to calculate the concentration of solvent taken up by each 
gram of wet cells. This appears to be about 3 mmoles, and to be remarkably consistent 
over the range of alcohols from ethanol to heptanol.
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10. Statistical Analysis
A comparison of the inhibition of progesterone hydroxylation by Cytochrome P450 1 l a  in 
whole cells of R. stolonifer (Figure 8-1) and the inhibition of sodium laurate 
hydroxylation by Cytochrome P450 BM3 in B. megaterium (Figure 6-4) was made in this 
section. Regression analysis was used to determine the statistical significance of the effect 
of alcohols on both hydroxylation reactions, and to determine whether there was any 
difference between the response of the two systems to the alcohol concentrations. This 
section explored the statistical methods used to obtain confidence in the final data and the 
conclusions obtained from the data.
10.1 Statistical analysis of errors
A normally distributed population is characterised by a mean and a standard deviation. 
The first, which is the population mean, centres the population, and the second, which is 
the standard deviation of the population, measures the spread around the centre.
In an experimental system an attempt is made to estimate both the mean and the standard 
deviation. Accurate values of either cannot be obtained even if the measurements are 
extremely accurate and precise because they are only a sample of the population. The 
sampling itself introduces errors, which cause the estimated values, the sample mean and 
standard deviation, to differ from the actual values, the population mean, and standard 
deviation.
A sufficiently large number of samples needed to be taken to ensure that the sampling 
errors were reduced to an acceptable level. For example if the sample were to contain just 
two measurements both might be to one side of the population mean, either high or low. 
The values could also be widely separated or perhaps close together. Wherever they lie 
there is clearly a high probability that they will provide a skewed estimate of the 
population mean and the standard deviation.
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10.1.1 Standard error of the mean, (SEM)
The standard error of the mean (SEM), that is the error associated with the estimate of the 
mean, can be calculated from the standard deviation (SD) of the measurements in the 
sample, which is taken. It equals SD/Vn where n is the number of measurements, which 
make up the sample. The SEM is the figure, which should follow the +/- sign (ie Mean +/- 
SEM), and should be used for the error bars. It is also used to compare means in Student’s 
t-test to check for the significance of a difference between the calculated means of two 
different populations.
10.1.2 Analysis of trends
Due to the instability of cytochrome P450 from B. megaterium in solution it was essential 
to prepare fresh samples of the enzyme from fermentation flasks and only one assay 
reading was recorded. Each of the R. stolonifer inhibition experiments could be carried 
out over many hours, but due to the time constraint it was decided to obtain only one 
estimate of the IC50 for each alcohol. The data for as many alcohols as possible was 
obtained, so as to fully understand the relationship between solvent inhibition and alcohol 
chain length.
Although each sample point represents a single measurement the data as a whole shows 
consistent trends (Sections 10.2.1 and 10.2.2). Where trends are recorded the data from 
neighbouring estimates ought to reinforce, because the sampled populations should be 
related. It is then possible to estimate the errors for the overall experiment even if  only 
one measurement is made at each point. However, to estimate the errors it is necessary to 
make some assumptions about how the variables are related.
10.1.3 Linear Regression analysis (Straight line relationship)
All of the data in these experiments was assumed to be related through linear trends. 
Where these are not immediately apparent some consistent transformation of the data was
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applied. The assumptions made are described later in the sections that describe the 
inhibition data itself.
Microcal Origin 4.1 was used to perform the linear regression analysis. The data was set 
up in an Origin data sheet, with the independent variable, for example the alcohol 
concentration, on the x-axis. The dependent variable, the one that was measured, for 
example the degree of inhibition, is plotted on the y-axis. Origin was used to fit a straight 
line to this data. The calculation sheet provided values for the correlation coefficient (r), 
and square root of the residual variance (SD).
The correlation coefficient (r), was used to check that the regression coefficient (the slope 
of the straight line) is significantly different from 0. A table of values for r, with n-2 
degrees of freedom, where n is the number of data points was used for this purpose.
The 95% confidence limits for the individual data points were calculated from the value of 
SD according to Equation 10-1. Microsoft Excel was used for this purpose.
Equation 10-1 Equation used to determine the 95% confidence limits
where xp is the value of x  for which the predicted value ofy is required, and Student’s t has 
a value appropriate to the 95% confidence limit (ie p<0.05) with n-2 degrees of freedom. 
Note that the variance of y about the regression line becomes larger the further you move 
away from T  |, the mean value of the independent variable.
The correlation coefficient and the 95% confidence limits contain the accumulated errors 
from all of the data used in their calculation.
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10.2 Results
10.2.1 B. megaterium
In each inhibition experiment with the separate alcohols we have used a range of 
concentrations and measured the respective hydroxylation activity (Figures 5-6 & 7-1). 
Appropriate alcohol concentrations were chosen to ensure that the levels of inhibition of 
the hydroxylation varied between 10 and 90%.
10.2.1.1 Effect of alcohols on the activity of progesterone hydroxylase activity in 
B. megaterium - Calculation from complete data set
Depending on the alcohol we have up to 8 data points from which to obtain a linear trend 
with the aim of measuring the IC50 for each alcohol. The mathematical function that 
describes that line is Y = BX + A where Y is the % enzyme activity, X is the Log(io) of the 
alcohol concentration, B is the slope of the line and A is the intercept on the Y axis. The 
concentration that produces 50% inhibition can then be obtained by calculating (50-A)/B.
Initially all of the experimental data obtained for was tabulated in Origin and the linear 
function Y = A + BX, the correlation coefficient, the standard deviation and the probability 
were calculated for each alcohol (Figure 10-1, Table 10-1).
The slopes of the lines (Figure 10-1) are all negative. But they are different across the 
range of alcohols tested. The spacing across the x-axis was also irregular, but as the chain 
length of the alcohol increases the intercept on the IC50 value increases.
The hexanol plot gives us a very low slope. This is because we are working at the limit of 
solubility and prevents us from obtaining experimental values of inhibition below about 
75%
In general this variation in the slopes is not what we would have expected from the 
original Osbome data (Osborne et al., 1990) where the slopes are much more regular 
(Figure 10-2).
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However a plot of the remaining hydroxylation activity against the alcohol concentrations 
actually produces a set of sigmoidal curves (Osborne et al 1990) and data taken from the 
extremes of high and low inhibition is not really not appropriate in fixing the mid point 
inhibition based on linear trends.
Alcohol N A B Corr
Coef
St. dev P Log(io)
[Ale]
Methano
1
8 41 -54 -0.989 4 <0 .0 0 0 1 -0.164
Ethanol 9 18 -75 -0.978 7 <0 .0 0 0 1 -0.422
Propano
1
7 -1 -57 -0.976 7 <0 .0 0 0 1 -0.880
Butanol 6 -33 -74 -0.936 1 2 0.006 -1.126
Pentanol 6 -2 1 -59 -0.911 11 0 .0 1 1 -1 .2 1 2
Hexanol 3 27 -25 -0.985 2 0 .1 1 0 -0.927
Table 10-1 Results of the regression analysis on the complete data set for the 
samples of B. megaterium. The data records a linear fit (Y = A + BX) to the 
relationship between the percentage activity and Log(io) alcohol for each 
alcohol.
1.2.1.2 Effect of alcohols on the activity of progesterone hydroxylase activity in 
B. megaterium - Calculation from reduced data set
When only the data covering inhibition from 20% to 80% is plotted the spacing and slope 
of the lines are much more regular, however the hexanol cannot be plotted. We would 
expect the spread of the data about the fitted line to reduce when using the restricted data 
set because of the sigmoidal nature of the inhibition data. Comparing the values of the
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standard deviations in the two plots (Figure 10-1 and Figure 10-3) can see this. There is 
also an increase in the correlation coefficients.
When comparing the spread of the data around the centre, the average standard deviation 
for the complete sample set is 7.2 whereas the average standard deviation for the reduced 
set is 4.2. This would suggest that the reduced set is more representative of a straight line 
from which the IC50 values can be calculated.
Alcohol N A B Corr
Coef
St. dev P Log(10)[Alc]
Methanol 6 41 -61 -0.955 4 0.003 -0.147
Ethanol 7 18 1 00 -0.992 3 0.000 -0.376
Propanol 4 -13 -77 -0.985 5 0.015 -0.814
Butanol 3 -183 -219 -0.995 3 0.060 -1.063
Pentanol 5 - 6 6 -95 -0.936 8 0.019 -1 .2 1 1
Table 10-2 Results of the regression analysis on the data set within the limits 
20% to 80% inhibition for the samples of B. megaterium. The data records a 
linear fit (Y = A + BX) to the relationship between the percentage activity and 
Log(io) alcohol for each alcohol.
10.2.1.2 Trend of inhibition of B. megaterium hydroxylase.
The derived values (Table 10-3) of the Log(io) Alcohol at 50% inhibition can then be 
plotted against the carbon chain length and a new linear trend fitted. The dotted lines 
show the 95% confidence limits calculated according to the equation shown (Section 
1.1.3).
All of the errors in the experiment are accumulated in this line (Figure 10-4). The 
advantage of setting up the data in this way is that it allows data from all of the alcohols to
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be used to measure the errors, even though each assay shown (Figure 10-1) was only 
performed once.
The dotted lines show the 95% confidence limits for the correlation. If you know the 
number of carbon atoms in the alcohol then a new estimate of the concentration of alcohol 
giving 50% inhibition should lie within the dotted envelope with a probability > 95%. 
Another way of looking at this is to say if we were to make another estimate of the alcohol 
concentrations at 50% inhibition and the value were to fall outside these dotted lines there 
is only a 5% chance that the difference would be due to random variation. In fact the new 
estimate which fell outside of these confidence limits would be significantly different from 
the value which the straight line predicts.
X2 Alcohol
(x)
Logj 0 [ale]
(y)
Mean E rror 5%
upper
5%
lower
1 1 -0.147 -0.1592 0.434 0.275 -0.593
4 2 -0.376 -0.4407 0.352 -0.088 -0.793
9 3 -0.814 -0.7222 0.325 -0.397 -1.048
16 4 -1.063 -1.0037 0.352 -0.651 -1.356
25 5 -1.211 -1.2852 0.434 -0.851 -1.719
Table 10-3 Tabulated values for the regression line for the relationship 
between Log(io) IC50 and carbon chain length for B. megaterium
10,2,2 R, stolonifer
10,2,2,1 Effect of alcohols on the activity of progesteone hydroxylase activity in 
R, stolonifer
The analysis of B. megaterium was replicated for R. stolonifer using all data points 
(Section 8.5.2). The results are tabulated in (Table 10-4 and 10-5).
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Alcohol N A B Corr
Coef
St. dev P Log(10)[Alc]
Methanol 4 84 -162 -0.961 19 0.039 0.2117
Ethanol 3 48 -121 -0.997 4 0.048 -0.0158
Propanol 4 26 -172 -0.926 22 0.074 -0.1381
Butanol 4 -31 -107 -0.981 10 0.019 -0.7504
Pentanol 3 -158 -156 -0.994 7 0.070 -1.3354
Hexanol 3 -249 -186 -0.998 4 0.036 -1.6086
Heptanol 3 -278 -157 -0.941 24 0.220 -2.0814
Table 10-4 Results of the regression analysis on the complete data set for the 
samples of R. stolonifer. The data records a linear fit (Y = A + BX) to the 
relationship between the percentage activity and Log(io> alcohol for each 
alcohol.
The actual values for the total alcohol concentrations which must be added to the system to 
cause 50% inhibition are for methanol 1.63 M, ethanol 0.96 M, propanol 0.73 M, butanol 
0.17 M, pentanol 46 mM, hexanol 21 mM, and heptanol 8 mM. These values are not very 
different from those used to estimate the concentration of alcohols that remain in the 
aqueous phase after partitioning into the cells of R. stolonifer (Section 9).
This is the final result of the effect of alcohols on the hydroxylase in R. stolonifer. The 
dotted lines show the 95% confidence limits for the correlation. If the number of carbon 
atoms in the alcohol is known, then the concentration of alcohol giving 50% inhibition 
should be found within the dotted envelope with a probability >95%.
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X2 Alcohol
(x)
Logi0[alc]
(y)
Mean Error 5%
upper
5%
lower
1 1 0 .2 1 2 0.390 0.606 0.996 -0.216
4 2 -0.016 -0.012 0.532 0.520 -0.545
9 3 -0.138 -0.415 0.488 0.073 -0.903
16 4 -0.750 -0.817 0.473 -0.344 -1.290
25 5 -1.335 -1.219 0.488 -0.731 -1.707
36 6 -1.609 -1.621 0.532 -1.089 -2.154
49 7 -2.081 -2.024 0.606 -1.417 -2.630
Table 10-5 Tabulated values for the regression line for the relationship 
between Log(io> IC50 and carbon chain length for R. stolonifer
10.3 Comparison of data from B. megaterium & R. stolonifer
The complexity of setting up the experimental conditions limited the number of trials that 
could be run. The two linear trends need to be compared to discover if there is a 
difference between the inhibition of the progesterone and sodium laurate hydroxylation 
reactions. Because of the limited data set, an analysis of the errors is required. We need to 
determine if the two lines are statistically different or similar.
10.4 Statistical analysis of the difference in slopes.
The analysis that Origin 4.1 gives us, does not directly compare the slopes of the two lines. 
The real question is whether the slopes (trends) of the two lines are different.
Simple linear regression analysis (above) was used to characterise the inhibition data for 
both B. megaterium and R. stolonifer separately. However multiple regression analysis 
can be used to compare the two sets of data and we have performed this analysis according 
to the techniques set out in section 11.10 of (Wackerly et al., 1995) and using the worked 
example 11.79 whose solution is set out in (Kincaid, 1996).
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The primary X and Y matrices were set up as below and the (3 matrix was derived directly 
from the simple regression analysis provided by Origin 4.1.
Y=
-0.147
-0.376
-0.814
-1.063
- 1.211
0.212
-0.016
-0.138
-0.750
-1.335
1 0 1 0
1 0 2 0
1 0 3 0
1 0 4 0
1 0 5 0
1 1 1 1
1 1 2 2
1 1 3 3
1 1 4 4
1 1 5 5
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0.1223 Po
0.6697 P.
p= -0.2815 P2
-0.1207 P3
Where;
(3o -  Slope for B. megaterium 
Po + Pi = Slope for R. stolonifer 
P2 — Intercept for B. megaterium 
P2 + p3 -  Intercept for R. stolonifer
SSE= 0.0519
s— 0.0930
n-(k+l)= 6
t= 2.9005
0.025>p>0.005
The analysis yields (above) a sum of the squares of the errors (SSE), and a standard 
deviation (S), shown. From this data a Student’s t value for the difference in the slopes at 
6 degrees of freedom (n-(k+l)) is calculated as 2.9, which is significant at a 5% 
probability.
10.5 Discussion.
It has been shown that the 2 slopes (Figure 10-3) are statistically different (Section 10.3). 
Therefore the partitioning effect alcohols in the two measured systems are significantly 
different.
Because of experimental limitations we are comparing a system with soluble enzyme and a
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system with membrane bound enzyme within a whole cell extract so we are measuring 
partitioning into the bulk membrane and not just the membrane associated with the 
enzyme. The partitioning of alcohol into the bulk membrane and the membrane associated 
with the enzyme may be different. We cannot then reach any conclusion about the 
comparison of partitioning of alcohols into membrane bound enzyme using a soluble 
enzyme as a control.
We can however use this simple test as a reference point for the analysis of membrane 
bound enzyme against a soluble control. If in future the experimental limitations found in 
this system can be overcome or a different system tested then the original hypothesis can 
be more fully tested.
At this stage we have developed an analytical tool for quickly and reliably measuring the 
partition coefficients and gone some way to test the original hypothesis.
159
o<
Complete data
100 -
■ MeOH
•  EtOH
2 0 - A  PrOH
▼ BuOH
♦  PentOH
0 - +  HexOH
-1.5 -1.0 -0.5
Log(10) (Alcohol)
Figure 10-1 Inhibition of P450 BM3 by various alcohols from methanol to 
hexanol. The percentage activity remaining is plotted against Log(io) alcohol 
concentration. All data points are included in the plot
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Figure 1 (a) 11a-Hydroxylase activity of R. nigricans in eight 
primary alcohol-aqueous cosolvent and two-liquid phase sys­
tem s as a function of the logarithm of the solvent concentration 
in the aqueous phase. C1, C2, etc. refer to the num ber of carbon 
atom s of the alcohol, (b) 11a-Hydroxylase activity of /?. nigricans 
in four organic-aqueous two-liquid phase system s as a function 
of the logarithm of the solvent concentration in the aqueous 
phase
Figure 10-2 Original Osborne data for the 1 la-Hydroxylase activity of 
R. nigricans in eight primary alcohol-aqueous cosolvent and two-liquid phase 
systems as a function of the logarithm of the solvent concentration in the 
aqueous phase.
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Restricted data set for 20% to 80% inhibition
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Figure 10-3 Inhibition of P450 BM3 by various alcohols from methanol to 
hexanol. The percentage activity remaining is plotted against Log(io) alcohol 
concentration. Only data between 20% and 80% inhibition is included.
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Figure 10-4 Regression line for the relationship between Log(io) IC50 and 
carbon chain length for B. megaterium.
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Figure 10-6 Regression analysis for the inhibition of P450 BM3 and P450 11a 
from Figures 10-4 and 10-5.
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11. Discussion
11.1 Developing the solvent partitioning assay
The first of the experimental aims was to develop an assay technique to measure the 
partitioning of an organic solvent into the biological membranes of microorganisms. 
Ideally the measurement should be made without separating the two phases, because at 
high partition coefficients the contamination caused by a small amount of membrane in the 
aqueous phase would lead to large errors in the analysis. The method should report only 
on the aqueous phase of the system. This should be possible with the luciferase assay, as 
demonstrated (Franks & Lieb, 1986). Other assays are also available but they report on 
both the solvent associated with the membrane and solvent in the aqueous phase.
Once the luciferase assay is set up, it does provide, as demonstrated by (Franks & Lieb, 
1986), a direct report on the aqueous concentration of the solvents. It’s applicable to a 
wide range of solvents, requiring only that the necessary standard curves be established for 
each of the solvents used. Other enzymes might be used in a similar fashion, but the light 
output form the luciferase assay is easy to measure directly.
There were some experimental problems with the setting the assay that were not initially 
envisaged. More time was spent on this part of the project but it was worth the effort 
because of the stable assay system that was developed, which was able to measure the 
aqueous concentrations of primary alcohols from methanol to pentadecanol, and alkanes 
from hexane to pentadecane.
11.2 Obtaining and comparing similar enzyme types
The second aim was to compare the effect of organic solvents on a soluble and a 
membrane bound enzyme. Cytochrome P450 was chosen because it is convenient and is 
available in both forms. We compared membrane bound Cytochrome P45011a
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hydroxylase from whole cells of R. stolonifer and soluble Cytochrome P450 BM3 from 
B. megaterium. The ideal enzyme for comparison would have been one that was available 
both in a soluble and in a membrane bound form. Were not able to compare a series of 
membrane bound enzymes as we initially forecast for the work.
11.3 Measuring Partition Coefficients
The ability of a solvent to inhibit the activity of a membrane-bound enzyme is related to 
two attributes. These are its solubility in water and its distribution ratio or partition 
coefficient between the membrane and the aqueous phases. The partition coefficient is 
defined as the ratio of the concentration of solvent in the aqueous phase and the 
concentration of solvent in the second phase. The second phase in this case being the 
biological membrane. Both the partition coefficient and solubility must be sufficiently 
high so that the solvent can deliver enough molecules from the aqueous phase into the 
biological membrane to reach the concentration required for inhibition.
For an accurate determination of solvent concentration in the membrane, the volume of the 
membrane phase and the partition coefficient must be known. Partition coefficients cannot 
easily be measured because we don’t know the volume of the membrane phase. Since 
biological membranes are a complex mixture of lipid and water, the measured volume of 
hydrated membrane would be an overestimate of the true volume of the unhydrated lipid.
Moreover biological membranes that have specific functions may have different structures 
that support for that function. Specific membranes may have a specific affinity for a 
particular organic solvent. Different membranes are likely to have different partition 
coefficients, and the concentration of solvents in each of them will be different, but the 
aqueous concentration will reflect this mixture, because all of the phases are in 
equilibrium.
For this reason the dissolution of alcohols and other solvents in cellular membranes is 
usually predicted by the use of octanol/water partition data, but a more direct estimate is 
possible using the systems developed and described in this thesis. It allows for the 
possibility that different membrane systems may respond in different ways to a particular 
group of solvents.
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We measure the partition coefficient of the solvents into the cell as a whole. In this system 
the luciferase will report on the concentration in the aqueous phase, and the cytochrome 
P450 itself will report on the membrane phase. Since we keep the membrane volumes 
constant we were able to compare the effect of a group of solvents on each enzyme.
11.4 Profile of Inhibition
One aim of the thesis was to look for evidence of the idea that there is a critical solvent 
concentration in the membrane at which the enzyme is inhibited, and to propose this as the 
primary effect in the link between Log P and the inhibition of enzyme activity.
Using the method developed to determine the amount of solvent associated with 
membranes, the relationship between the inhibition of two P450 enzymes with the amount 
of solvent in the aqueous phase has been investigated. The partitioning of alcohols into 
the membrane phase has been estimated directly rather than indirectly from partition 
coefficient data obtained in model systems (Log Poet).
This is demonstrated by the inhibition of P450 11a from R. stolonifer by a homologous 
series of alcohols. Methanol, the first of the series has a high solubility in the aqueous 
phase (in practice it is completely miscible). Methanol also has a low partition coefficient 
between a membrane and aqueous phase. As the homologous series is ascended the 
solubility of the alcohol in the aqueous phase decreases and the partition coefficient 
increases.
The effect of the solvents as inhibitors in the reaction mixture was characterised by their 
IC50. The soluble enzyme from B. megaterium was more strongly inhibited by short chain 
alcohols (IC50 for methanol = 0.71 M) than the enzyme from R. stolonifer (IC50 for 
methanol = 1.63 M). The inhibition of both enzymes by the primary alcohols becomes 
more extreme as their molecular weight increases, and they are about equally inhibited by 
pentanol. (ICso= 62 mM & 46 mM respectively). Hexanol inhibits the enzyme from 
R. nigricans (IC5o=25 mM), but it is not sufficiently soluble, solubility limit in water
50.1 mM, (Bell, 1972) to inhibit the enzyme from B. megaterium.
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These concentrations of solvent are the totals added to the assay mixtures. In the case o f  
R. stolonifer they are therefore greater than the actual aqueous concentrations, because 
some solvent is taken up by the membranes of the wet cells. However over the range of 
alcohols studied the amount of alcohol removed from the aqueous phase reduces its 
concentration by about lOmM.
The evidence for the critical membrane concentration is based on the cut-off beyond which 
alcohols do not inhibit, and on the regular relationship between IC50 and C chain length. 
The specific membrane concentration at which a member of a solvent group inhibits 
enzyme activity within the membrane can be estimated from the aqueous solubility and the 
partition coefficient. The data in Table 10-6 suggest that this occurs when each gram of 
wet cells contain about 3 mmole alcohol, but we do not know how this is distributed 
amongst the various membrane phases.
The concept of a critical membrane concentration does explain the sudden transition from 
compatible to non-compatible solvents as Log P increases because although the partition 
coefficients are increasing the aqueous solubilities of the solvents are decreasing even 
faster.
Since the ability of molecule to inhibit enzyme reaction in a two-phase system is related to 
the product of the solubility in the aqueous phase and the partition coefficient, the limiting 
factor for long chain molecules would be the solubility in the aqueous phase.
Conversely the limiting factor for short chain molecules would be the partition coefficient. 
As the homologous series is ascended effect increases until the solubility in the aqueous 
phase falls to a level that cannot support inhibition in the membrane phase. This is the 
membrane concentration cut off effect.
11.5 Comparison of the inhibition of P450 BM3 and P450 11a
The inhibition of purified P450BM3 (Figure 5-7) and of P450 11a in whole cells of 
R. stolonifer (Figure 7-2) by alcohols demonstrates the importance of this difference. In 
each case as the chain length increases the ability to inhibit the enzyme activity increases
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until a chain length is reached where no inhibition is caused. For P450 BM3 hexanol 
cannot reach an IC50 concentration whereas with P450 1 la in whole cells of R. stolonifer 
hexanol can effect an IC50 inhibition but octanol cannot. P450 BM3 can tolerate hexanol in 
the system with only a 25% reduction in the activity of transformation. However the 
membrane bound P450 1 la  is inactive in the presence of this solvent. Purified P450 BM3 
is therefore more resistant to alcohols than the membrane enzyme P450 1 la by two carbon 
units. Since the substrates of many biotransformations are relatively hydrophobic, purified 
enzymes in this case could be used to increase the variety of organic solvents used to 
increase process pressures on the cytochromes P450 when used as a bioreactor.
The results demonstrate that there are differences between the two enzymes studied.
From the experimental observations we can conclude that for a homologous series of 
solvents the concentration of solvent bound required to cause inhibition of a fixed ratio of 
enzyme activity is relatively fixed. As the chain length of the inhibitor increases so too 
does the partition coefficient. Although we were unable to measure the partition 
coefficient directly, because the volume of the membrane was unknown, the results are 
very similar to those observed in the action of general anaesthetics. This strongly suggests 
that the amount of solvent per gram of cells remains relatively constant over the range of 
alcohols studied
11.6 Industrial Use
The rate of microbial hydroxylation of progesterone by Aspergillus ochraceous increases 
by the addition of a separate organic phase (Ceen, 1986). Loss of P450 11a hydroxylase 
activity is very rapid and almost complete within 10 minutes. This limits the industrial use 
of a second organic phase in large-scale biotransformations. An attempt to purify P450 11 
a from whole cells resulted in loss of activity even at the homogenisation step (Thomas, 
1994). A series of ^-alcohols were tested for their effect on the operational stability in a 
two-phase system (Osborne, 1990). All lower alcohols tested resulted in the complete 
loss of activity with the exception of hexanol. R. stolonifer retained 50 % of the activity 
within 10 minutes of incubation with hexanol.
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The membrane bound P450 system has been shown to be made up of four proteins: 
cytochrome P450, NADPH-cytochrome P450 reductase, cytochrome b5, and cytochrome 
b5 reductase (Madyashtha et al., 1984). The substrate binding site of membrane bound 
cytochrome P450 directly faces the vertical plane of the lipid bilayer (Taniguchi et al., 
1984). The NADPH-cytochrome reductase must be continually recycled to preserve 
activity.
Theories have been presented to explain the deactivation of membrane bound enzymes. 
These include alteration of membrane fluidity, lipid phase separations, direct solvent - 
protein interactions, and membrane permeabilisation. Each may contribute to the overall 
reduction in the rate of activity of the membrane bound P450, but only direct solvent - 
protein interaction can explain the reduction in fatty acid hydroxylation exhibited by 
P450 BM3, since this occurs in the cytoplasm and in our experiments has been purified to 
homogeneity.
In both P450 enzymes it was noticed that at low concentrations of solvent an increase in 
hydroxylase activity was seen. It has been reported that benzyl alcohol at membrane 
concentrations of 20-100 mM caused increases in the activity of seven different 
membrane-bound enzymes (Gorden et ah, 1980). Membrane expansion and increased 
membrane fluidisation have been cited as a cause of this increased activity. An increase in 
membrane fluidity may allow more rapid diffusion of substrate into the membrane, 
resulting in higher collision frequency and higher observed rate of reaction. This 
explanation is not valid for P450 BM3, which is a soluble enzyme. The phemonenon has 
also been seen with the effect of both alkanes and alcohols on the pure bioluminescent 
enzyme luciferase (Section 2). Increased reaction rates could be a result in increased 
collision frequency or the stability of the transition state complex. Solvents may be 
beneficial in this respect.
As the solvent concentration is increased further a rapid reduction of initial activity is 
noted with both bound and unbound P450 enzymes. In the membrane case this may be 
due to a disruption of the enzyme-membrane architecture. Uncoupling of P450 activity to 
the solvent was examined and found not to be relevant. In the case where no membrane is
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present the enzyme activity is retained at concentrations that would produce complete 
inactivation of the initial activity of the membrane bound enzyme. This suggests that the 
membrane bound enzyme the functionality is determined by the support and when the 
support is disrupted all activity is lost. The cytochrome itself, like P450 BM3, may be 
significantly more resistant to the effects of the solvents.
Some higher solvents studied produced no inactivation even at saturating concentration. 
This is attributed to their inability to reach a particular critical concentration in the 
membrane. For the range of /7-alcohols from methanol to heptanol, the amount of alcohol 
per gram of membrane to cause inhibition to 50% is ~3 x 10'3 moles (Table 8-2). This 
concentration remains relatively fixed when compared to the calculated aqueous 
concentration required to cause I C 5 0  inhibition (1200 mM for methanol decreasing to 
6 mM for heptanol, (Table 8-2).
The saturated solutions of alcohols from methanol to heptanol have a sufficient 
concentration in the aqueous phase to partition enough molecules of solvent into the 
membrane to cause IC50 inhibition (~3 x 10' moles). Above heptanol even though the 
ability of this alcohol to partition into the membrane increases, the aqueous concentration 
is not high enough and the number of octanol molecules able to partition (determined by 
the true membrane / buffer partition coefficient) is not enough to exceed 3 mM/g.
It is possible that most homologous series behave in a similar way. Several of the systems 
for which (Laane et al., 1985) showed the sigmoidal Log P-activity retention correlation 
resemble those presented in this thesis; that is, they were for microbial whole cell 
performing a conversion using a membrane-bound enzyme. The explanations for the 
observed correlation are therefore likely to be similar to those presented here. The 
increase in fluidity cannot explain the results with P450 BM3 or with luciferase.
To aid the selection of solvents in the future, it is necessary to determine the membrane 
concentrations for at least the lower members of the group. The limiting chain length 
relating to the cut-off effect and the solvent that allows for full activity can then be 
predicted and used.
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Organic solvent selection can now be obtained for any two liquid-phase systems rationally. 
Critical membrane concentrations can be obtained in a simple and reliable manner using 
the stabilised form of luciferase. This allows for the elimination of a large number of 
solvents expected to cause complete loss of enzyme activity in industrial reactors.
11.7 Implications to anaesthesia
The critical membrane ‘concentration’ to cause the inhibition of membrane protein has 
been determined but the action on the molecular level has yet to be determined but some 
form of protein-membrane disruption is the favoured hypothesis from the results of this 
work
The work by (Franks & Lieb, 1984) indicated that the site of general anaesthesia could be 
protein based rather than the membrane theories traditionally accepted. They 
demonstrated how the cut off effect could be explained by the use of a membrane protein 
target site of anaesthetics with the use of purified luciferase. Cytochromes P450 have been 
suggested as possible protein target (Franks & Lieb, 1987). For R. stolonifer a direct 
determination of membrane I C 5 0  concentrations has shown that the inhibition of a 
membrane protein can be effected at the same concentration of a number of alcohols of 
differing chain length at a single concentration at the membrane. This supports the protein 
target hypothesis of anaesthesia. Attempts to correlate the E C 5 0  data for a range of isolated 
organs and animals fails to give good correlation and P450 11a seems to be effected by 
higher alcohols to a greater extent than for mammalian P450 systems (Table 10-3).
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si-Alcohol E C 5 0  (mM) Logio E C 5 0 IC50 (mM) Logio I C 5 0
Methanol0 790 2.898 1 3.09691
Ethanol* 263 2.420 1000 3
Butanolc 1 1.256 200 2.30103
Pentanol*7 2.9 0.462 50 1.69897
Table 11-1 Relationship between anaesthetic potency (EC50) and potency of 
inhibition for inhibition of progesterone metabolism (IC50).
E C 5 0  values are derived from studies on isolated organs, aquatic organisms, and animals. 
References for each value are as follows (cf. Superscripts in the table): a, 590 (Alifimoff et 
al 1989), 990 (Vernon, 1913); b, 190 (Alifimoff et al 1989); 410 (Vemon, 1913); 330 
(Meyer and Hemmi 1935), 120 (Pringle et al. 1981); c, 10.8 (Alifimoff et al 1989), 22.3 
(Vemon, 1913), 30 (Meyer and Hemmi 1935), 12.0 (Pringle et a l 1981); 17.0 (Paton 
1974); 13.4 (Elliott and McElwee 1988); d , 2.9 (Alifimoff al 1989), 3.2 (Elliott and 
McElwee 1988); 2.5 (Roth 1980).
11.8 Implications to industrial solvent issues
Simple tests have been developed to determine the maximum chain length of a 
homologous series that would support a biotransformation in the aqueous solvent mixture. 
Given that we know the range of solvents that can be utilised what chain length should be 
used and what homologous series should be chosen? These choices would be affected by 
the regulatory affairs, solvent formulation, health and recovery issues.
11.8.1 Introduction
Industrial solvents are generally liquid organic compound used on a large scale. Compared 
with the large amount of potential liquid organic compounds available, economic, safety, 
manufacturing and environmental issues limit scope to a few chemical classes. Aromatic
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and aliphatic hydrocarbons, alcohols, ketones, esters, glycols, glycol ethers, chlorinated 
hydrocarbons, amines and aldehydes.
The selection of a suitable solvent and blend development is a combination of the issues 
raised in the previous paragraph.
11.8.2 Regulatory affairs
Since 1966, new and more restrictive regulations have been adopted by the controlling 
bodies in both the European Economic Community (ECC) and the numerous organisations 
in the USA. Regulations have been a driving force in the development of new 
technologies and products that decrease solvent emissions to minimise environmental 
impact.
European and US air quality standards have been set for ozone levels and although solvent 
operations do not emit ozone directly, solvents, as volatile organic compounds (VOCs), 
react with nitrogen oxides in the atmosphere to produce photochemical smog, of which 
ozone is a significant component.
Different regulatory approaches have been adopted that lower total VOC levels and restrict 
the range of allowable compounds to those that have a low photochemical reactivity and so 
give a smaller contribution to the smog levels.
The clean air act, as amended in 1990 represent a more recent effort by the US congress to 
address clean air concerns. A compliance timetable by category as been established, 
which depends on the level of current ozone concentration. The definition of a major 
source also depends on the category of ozone non-attainment (Table 11-2). The reduction 
of hazardous air-pollutants also feature in the amendments and is regulated by the 
Environmental Protection Agency (EPA). The EPA insist in the installation of maximum 
achievable control technology (MACT) and once MACT controls have been met further 
control is applied to reduce residual emissions.
It is clear that the use of organic compound in the chemical industry is under ever more 
strict regulation and that the range of compound that can be used is decreasing rapidly. 
There is a constant drive to remove all organic compounds out of the manufacturing 
process. The use of free enzymes or whole cell bio-reactors in modem large scale bio-
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processing will ultimately be a trade of between safety and cost-benefit of using such 
technology.
Classification Deadline to attain M ajor VOC source, t/ty
Marginal Nov. 15, 1993 100
Moderate Nov. 15, 1996 100
Serious Nov. 15, 1999 50
Severe Nov. 15, 2005 to Nov. 2007 25
Extreme Nov. 15, 2010 12
Table 11-2 VOC Emission is Reduction/Ozone Attainment Schedule
11.9 Solvent Recovery
The recovery of valuable solvents is an important factor in determining the overall 
economics of a chemical and biochemical large-scale process. Processes employing 
solvents have generally included solvent-recovery systems. Solvent recovery issues 
relating to MACT and the cost of solvents difficult to produce have directed the 
development of complex solutions to the problem.
In our hypothetical bio-reactor the chosen solvent is recycled after the separation of 
substrates, products, and possibly enzyme depending on cost.
Efficient solvent recovery will result in low solvent use, and therefore low activity in the 
manufacture of chemicals specifically for solvent applications.
11.9.1 Solvent-Recovery Systems
Many solvent-recovery operations are based on the same techniques, such as absorption, 
adsorption, extraction, filtration, distillation, and condensation. The same factors such as 
volatility, solubility, thermal stability, corrosion, purity requirements, capacity, steam and 
water conditions, safety, and economics must be taken into account.
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11.9.2 Solvent -Recovery Techniques
11.9.2.1 Mechanical Separation
Draining of liquids from solids is a common operation in solvent processes. The solids are 
usually retained either by stationary or moving screens by some form of agitation. 
Centrifugal filters and solid bowl centrifuges use centrifugal force to increase the 
efficiency of filtering but lead to an increase demand for power. This process is best suited 
for product recovery systems where the substrate can be recycled without loss or with a 
low cost substrate (relative to product).
11.9.2.2 Extraction
Solvent and product are sometimes separated by washing with water or another solvent 
(Robbins, 1979).
Low viscosity solvents can be extracted with and aqueous wash. If the solvents are 
viscose however an emulsion may result giving rise to low extraction efficiencies. 
pH of the solution may be altered to alter the concentration of product in the aqueous or 
water phase. For example a change in pH from 7.5 to 2.5 converts penicillin form a 
preferentially water-soluble compound to a preferentially organic soluble one.
11.9.2.3 Evaporation
Simple evaporation and condensation can recover organic solvents. The cost of 
evaporating solvent increases with the chain length and for higher chain length compounds 
that are solid at room temperature, elevation of pressure or temperature would have to be 
employed increasing the cost of the process.
11.9.2.4 Other processes
These include fractional distillation, drying in the absence of air or inert gas, drying with 
air or inert gas, condensation, absorption, and adsorption.
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11.10 Process Economics
Solvent-recovery decisions are based mainly ion economic analysis. Such analysis 
involves not only careful engineering calculation, but also a prediction of future prices of 
raw materials, utilities, and products, of interest rates on borrowed capital, tax rates, and of 
government standards and regulations with regard to pollution and occupational safety. 
Methanol, for instance, is easily dehydrated by straight fractional distillation. Ethanol and 
propanol form constant -boiling mixtures with water. Butanol is easily dehydrated since 
the two layers can be decanted and stripped. When purification of the recovered solvent is 
difficult, a less pure solvent might be acceptable for recycling.
11.11 Health and Safety Factors
Safety considerations may ultimately form the basis for choosing a particular solvent and 
determine the recovery process. Organic solvents not only pose a flammable threat but 
also the solvent vapours can be neurotoxic, for example in the case of long chain alcohols. 
Increased interest in the long-range effect on human health exposure to solvents and other 
chemicals have led to the development of ‘cradle-to-grave stewardship’ over the chemicals 
they used or produce, monitoring both their own and their customers’ safety precautions. 
The effect of these developments on solvent-recovery and the choice of organic solvents 
will, of course, be an increased preference for innocuous solvents and for systems giving 
essentially complete recovery.
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12. Future work
12.1 The solvent assay
The production of substrate-stabilised enzyme could be developed to further improve the 
stability. This would have implications on storage and cost if  the detection kit was used in 
a large scale.
To modify the purification procedure, reducing the number of steps. Isolation of 
P450 BM3 from E. coli would give benefits to the procedure and could yield higher 
process efficiency.
To estimate the uptake of solvents into the cells, under a wider range of conditions than 
was possible in the present experiments. These would include the effect of cellular age 
and growth, the effect of temperature and the effect of cell concentration. The latter 
should improve the accuracy of the estimate of solvent uptake.
12.2 Testing other Solvents
Although both n-alkanes and n-alcohols were used to develop and test the luciferase assay, 
only n-alcohols were tested with the soluble and membrane bound Cytochromes because 
of time constraints. Investigating n-alkanes would give a good opportunity to test if the 
molecular cut off effect was apparent in other chemical groups.
Determining the effect of other ^-alcohols with the same Poet value on the activity of both 
hydroxylases would yield information relating the effect of molecular shape on the 
inhibition. The comparison of the two enzymes should extend through a much wider 
range of solvents.
Immobilisation of whole cell membrane fragments on to a hydrophobic resin could be
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investigated to discover if this had any effect on the inhibition.
12.3 Engineered Enzymes
In our original experiments we were not able to obtain a membrane bound enzyme that 
would report on the concentration of solvent in the membrane phase with a soluble version 
of the same enzyme acting as a control. Genetic engineering gives the biochemist the tools 
to change the structure and function of many enzymes. Genetic engineering may yield a 
membrane free mutant of P450 11a. We could test the wild form with the mutant as the 
control enzyme. In the future different Cytochromes may be expressed in the cellular 
membranes of other species. Once this has been achieved, using the tools developed in 
this thesis it would be possible to test a variety of situations not available to us, and to 
move the same enzyme in different cellular locations. We could test the partitioning of 
solvents into a range of membranes and determine if  the structure of these different 
membranes affects the partitioning of solvent.
Genetic engineering may also be able to produce an over-expressed membrane bound 
Cytochrome P450. Since the proportion of membrane containing P450 would be higher 
than the wild form a test could be developed to determine if the different membrane types 
within a species have different partition characteristics.
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